Document:

<PAGE>

                                                                  EXHIBIT 10.1

                      INNOVATIVE CLINICAL SOLUTIONS, LTD.
                             2000 STOCK OPTION PLAN

    1.  PURPOSE

    Innovative Clinical Solutions, Ltd. (the "Company") desires to attract and
retain the best available talent and encourage the highest level of performance
by employees and other persons who perform services for the Company in order to
serve the best interests of the Company and its stockholders. By affording
eligible persons the opportunity to acquire proprietary interests in the Company
and by providing them incentives to put forth maximum efforts for the success of
the Company's business, the Innovative Clinical Solutions, Ltd. 2000 Stock
Option Plan (the "Plan") is expected to contribute to the attainment of those
objectives.

    2.  OPTIONS AND SHARES OF COMMON STOCK SUBJECT TO THE PLAN

    Option grants under the Plan may be granted in the form of (i) incentive
stock options ("incentive stock options") as provided in Section 422 of the
Internal Revenue Code of 1986, as amended (the "Code"), to purchase shares of
the common stock, par value $0.01 per share, of the Company (the "Common
Stock"); (ii) options to purchase shares of Common Stock which are not intended
to qualify as incentive stock options ("non-qualified options") (unless
otherwise indicated, references in the Plan to "options" include incentive stock
options and non-qualified options) or (iii) any combination of the foregoing as
the Committee (as defined in paragraph 3(a)) shall determine. The maximum
aggregate number of shares of Common Stock as to which options may be granted
from time to time under the Plan is 2,285,714 shares,(1) of which 142,855
shares(2) will be available for grants to nonemployee directors and the balance
shall be available for grants to other eligible participants, in each case
subject to adjustment as provided in paragraph 11. The shares available may be
in whole or in part, as the Board of Directors of the Company (the "Board of
Directors") shall from time to time determine, authorized but unissued shares or
issued shares reacquired by the Company. Unless otherwise provided by the
Committee, shares covered by expired or terminated options will be available for
subsequent option grants under the Plan. Any shares issued by the Company in
respect of the assumption or substitution of outstanding options from a
corporation or other business entity by the Company shall not reduce the number
of shares available for option grants under the Plan.

    3.  ADMINISTRATION

        (a)  The Plan shall be administered by a committee (the "Committee")
consisting of not less than two members of the Board of Directors who are
selected by the Board of Directors. The term "Committee" shall refer to the
Board of Directors if at any time no committee of the Board of Directors is
constituted to administer the Plan.

        (b)  The Committee shall have plenary authority in its discretion,
subject to and not inconsistent with the express provisions of the Plan (i) to
grant options, (ii) to determine the purchase price of the shares of Common
Stock covered by each option, (iii) the term of each option, (iv) the persons to
whom, and the time or times at which options shall be granted, (v) the number of
shares to be covered by each option, (vi) to designate options as incentive
stock options or non-qualified options, (vii) to interpret the Plan, (viii) to
prescribe, amend and rescind rules and regulations relating to the Plan,
(ix) to determine the terms and provisions of the option agreements as described
in paragraph 14 (which need not be identical), and (x) to make all other
determinations deemed necessary or advisable for the administration of the Plan.
Except to the extent prohibited by any applicable law, rule or regulation,
including, without limitation, the requirements applicable under Section 162(m)
of the Code to any option granted under the plan intended

------------------------
(1)   Sixteen percent of outstanding Common Stock on a fully diluted basis on
     the Effective Date of the Plan.

(2)   One percent of the outstanding Common Stock on a fully diluted basis on
     the Effective Date of the Plan.

ICSL STOCK OPTION PLAN
<PAGE>
to be "qualified performance-based compensation," or the requirements for any
award granted under the Plan to an officer or director to be covered by any
exemptive rule under Section 16 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") (including Rule 16b-3, or any successor rule, as
the same may be amended from time to time), the Committee may delegate to one or
more of its members or to one or more agents such administrative duties as it
may deem advisable, and the Committee or any person to whom it has delegated
duties as aforesaid may employ one or more persons to render advice with respect
to any responsibility the Committee or such person may have under the Plan.

        (c)  The Committee may employ attorneys, consultants, accountants or
other persons and the Committee, the Company and its officers and directors
shall be entitled to rely upon the advice, opinions or valuations of any such
persons. The Committee shall have full discretionary authority in all matters
related to the discharge of its responsibilities and the exercise of its
authority under the Plan. All actions taken and all interpretations and
determinations made by the Committee in good faith shall be final and binding
upon all persons who have received option grants, the Company and all other
interested persons. No member or agent of the Committee shall be personally
liable for any action, determination or interpretation taken or made in good
faith with respect to the Plan or option grants made thereunder, and all members
and agents of the Committee and the Board of Directors shall be fully
indemnified and protected by the Company in respect of any such action,
determination or interpretation.

    4.  ELIGIBILITY; FACTORS TO BE CONSIDERED IN GRANTING OPTIONS

        (a)  Subject to the limitations on the granting of options otherwise set
forth in the Plan, option grants will be limited to employees and directors
(whether or not also employees) of the Company or a Subsidiary (as defined in
the last sentence of this paragraph 4(a)) and to individuals who are not
employees but who provide services to the Company or a Subsidiary, but only to
the extent any such non-employees (i) are natural persons; (ii) provide BONA
FIDE services to the Company or a Subsidiary; and (iii) provide services that
are not in connection with the offer or sale of the Company's or a Subsidiary's
securities in a capital-raising transaction, and do not directly or indirectly
promote or maintain a market for the Company's or a Subsidiary's securities
(such service providers who are neither employees nor directors are referred to
in the Plan as "consultants"). In determining the eligible individuals to whom
options shall be granted and the number of shares to be covered by each option,
the Committee shall take into account the nature of the individuals' duties,
their present and potential contributions to the success of the Company and such
other factors as it shall deem relevant in connection with accomplishing the
purposes of the Plan. An eligible individual who has been selected by the
Committee to participate in the Plan and who holds an outstanding option under
the Plan is referred to in the Plan as an "optionee." As used in the Plan,
"Subsidiary" shall mean any present or future corporation which is or would be a
"subsidiary corporation" of the Company as such term is defined in
Section 424(f) of the Code.

        (b)  Option grants may be granted singly, in combination or in tandem
and may be made in combination or in tandem with, in replacement of, or as
alternatives to, awards or grants under any other employee plan maintained by
the Company and/or any Subsidiary. No incentive stock option shall be granted to
any individual otherwise eligible to participate in the Plan who is not an
employee of the Company or a Subsidiary on the date of granting of such option.
An optionee who has been granted an option or options under the Plan may be
granted additional options, subject to such limitations as may be imposed by the
Code on the grant of incentive stock options. No grant of incentive stock
options (under the Plan and any other "incentive stock option" plans of the
Company, any Subsidiary and any "parent corporation" of the Company within the
meaning of Section 424(e) of the Code) shall result in the aggregate fair market
value of Common Stock with respect to which "incentive stock options" (within
the meaning of Section 422 of the Code, but without regard to subsection (d) of
such Section) are exercisable for the first time by any employee during any
calendar year (determined at the time the incentive stock option is granted)
exceeding $100,000.

ICSL STOCK OPTION PLAN                 2

<PAGE>
        (c)  Notwithstanding any other provision contained in the Plan to the
contrary, the maximum number of shares of Common Stock which may be subject to
options granted under the Plan to any single optionee during any calendar year
shall not exceed 457,143 shares of Common Stock.

        (d)  As of the effective date of the Plan, nonqualified options,
evidenced by Agreements substantially in the form of APPENDIX A hereto, shall be
granted to the employees of the Company, as listed on SCHEDULE I hereto, to
purchase the number of shares of Common Stock that are allocated on SCHEDULE I
to such employees, at the option exercise price as specified in paragraph 5(c),
subject to proportionate adjustment as otherwise provided in paragraph 12 and
the other terms and conditions of the Plan and such Agreements.

        (e)  As of the effective date of the Plan, nonqualified options
evidenced by Agreements substantially in the form of APPENDIX B hereto shall be
granted to the directors of the Company as listed on SCHEDULE I hereto, to
purchase the number of shares of Common Stock that are allocated on SCHEDULE I
to such directors, at the option exercise price as specified in paragraph 5(c),
subject to proportionate adjustment as otherwise provided in paragraph 12 and
the other terms and conditions of the Plan and such Agreements.

        (f)  The adoption of the Plan shall not be deemed to give any employee
of the Company or any Subsidiary or any other person any right to be selected to
participate in the Plan or to be granted an option under the Plan. No person
shall have any rights or claims under the Plan except in accordance with the
provisions of the Plan and the applicable option agreement.

    5.  PURCHASE PRICE

        (a)  The purchase price of a share of the Common Stock covered by each
option shall be determined by the Committee, but, subject to paragraphs 5(b) and
5(c), shall, in the case of any incentive stock option, not be less than 100% of
the fair market value (as hereinafter defined, the "Market Value") of a share of
the Common Stock on the date such incentive stock option is granted, and such
purchase price of any option granted under the Plan shall not be reduced, by
action of the Committee or the Board of Directors or otherwise, at any time
after the date such option is granted (subject to Section 11(a)). For purposes
of the Plan, the Market Value of a share of Common Stock shall be the closing
price for a share of Common Stock on the date of the determination, or if such
date is not a trading day, then on the most recently preceding trading day;
PROVIDED, HOWEVER, that for purposes of any incentive stock options granted
under the Plan, such Market Value shall be determined subject to
Section 422(c)(7) of the Code. The closing price for a share of Common Stock
shall be: (i) if the Common Stock shall be listed or admitted to trading on any
national securities exchange, the average of the last reported sales prices on
the specified days (or if there is no reported sale on any such trading date,
the average of the closing bid and asked prices on such trading date); (ii) if
the Common Stock is not traded or admitted to trading on any national securities
exchange, the closing price, if reported, or if the closing price is not
reported, the average of the closing bid and asked prices, as reported by The
Nasdaq Stock Market-Registered Trademark- or similar source or, if no such
source exists, as furnished by two members of the National Association of
Securities Dealers, Inc., selected by the Committee for that purpose, on the
specified dates; or (iii) if the Common Stock is not traded or admitted to
trading on any national securities exchange or The Nasdaq Stock
Market-Registered Trademark-, the closing price on such dates as determined in
good faith by the Committee or the Board of Directors. The Committee shall
determine the date on which an option under the Plan is granted, PROVIDED that
such date is consistent with the Code and any applicable rules or regulations
thereunder. In the absence of such determination, the date on which the
Committee adopts a resolution granting an option shall be considered the date on
which such option is granted, PROVIDED the optionee to whom the option is
granted is promptly notified of the grant and an option agreement is duly
executed as of the date of the resolution. The purchase price shall be subject
to adjustment as provided in paragraph 11(a).

ICSL STOCK OPTION PLAN                 3

<PAGE>
        (b)  No incentive stock option shall be granted to an employee under the
Plan who owns (within the meaning of Section 424(d) of the Code), at the time
the option is granted, more than ten percent (10%) of the total combined voting
power of all classes of stock of the Company or a Subsidiary or any "parent
corporation" of the Company within the meaning of Section 424(e) of the Code.
This restriction does not apply if at the time such incentive stock option is
granted the option exercise price per share of Common Stock subject to the
option is at least 110% of the Market Value of a share of Common Stock on the
date such incentive stock option is granted, and the incentive stock option by
its terms is not exercisable after the expiration of five years from such date
of grant.

        (c)  Notwithstanding the provisions of paragraph 5(a) to the contrary,
for purposes of determining the purchase price of shares of Common Stock covered
by options granted as of the effective date of the Plan, the Market Value of a
share of Common Stock shall be equal to the lesser of (i) the average of the
closing prices on the thirtieth (30(th)) through the sixtieth (60(th)) day
(inclusive) immediately following the Effective Date as determined in accordance
with paragraph 5(a) or (ii) $9.25926 multiplied by the average of the average of
the closing bid and asked prices of the Company's 6 3/4% Convertible
Subordinated Debentures due 2003 (the "Debentures") as reported by Interactive
Data Corporation for the five trading days immediately prior to filing of the
Prepackaged Plan referred to in paragraph 12 hereof with the U.S. Bankruptcy
Court, expressed as a percentage of the principal amount of the Debentures.

    6.  TERMS OF OPTION GRANTS

    The term of each option granted under the Plan shall be determined by the
Committee and set forth in the option agreement evidencing such option,
PROVIDED, HOWEVER, that, subject to paragraph 5(b) and earlier termination as
provided in paragraphs 9 and 10, no option shall be exercisable after ten
(10) years from the date such option was granted.

    7.  EXERCISE; LOANS

        (a)  Subject to the provisions of the Plan, an option granted under the
Plan shall become vested and exercisable as determined by the Committee and set
forth in the option agreement evidencing such option. The Committee may, in its
discretion, determine as a condition of any option, that all or a stated
percentage of the option shall only become exercisable, in installments or
otherwise, after completion of a specified period of service with the Company
and the Subsidiaries or subject to any other condition or conditions.

        (b)  The Committee may also, in its discretion, accelerate the
exercisability of any options at any time and provide, in any option agreement,
that the option shall become immediately exercisable as to all or any portion of
the shares of Common Stock remaining subject to the option on or following a
Change of Control (as defined in this paragraph). The date upon which a Change
of Control occurs shall be referred to herein as an "acceleration date"). A
"Change of Control" shall be deemed to have occurred as of the first day any one
or more of the following conditions shall have been satisfied:

        (i) Any individual, corporation (other than the Company or any
            Subsidiary), partnership, trust, association, pool, syndicate, or
            any other entity or any group of persons acting in concert (other
            than (x) any employee benefit plan (or any trust forming a part
            thereof) of the Company or any Subsidiary or (y) any person or group
            of persons who shall directly or indirectly own twenty percent (20%)
            or more of the Common Stock to be distributed as of the "Effective
            Date" in connection with the consummation of the "Prepackaged Plan"
            (as such terms are defined in the Prepackaged Plan referred to in
            paragraph 12)) becomes the beneficial owner, as that concept is
            defined in Rule 13d-3 promulgated by the Securities and Exchange
            Commission under the Exchange Act of securities of the Company
            possessing either (X) thirty percent (30%) or more of the voting
            power for the election of directors of the Company or (Y) thirty
            percent (30%) or more in value of the outstanding equity securities
            (or the right to acquire thirty (30%) per cent or more) of the
            Company;

ICSL STOCK OPTION PLAN                 4

<PAGE>
        (ii) There shall be consummated any consolidation, merger, or other
             business combination involving the Company or the securities of the
             Company in which (X) holders of voting securities of the Company
             immediately prior to such consummation own, as a group, immediately
             after such consummation, voting securities of the Company (or, if
             the Company does not survive such transaction, voting securities of
             the corporation surviving such transaction) having less than fifty
             percent (50%) of the total voting power in an election of directors
             of the Company (or such other surviving corporation) or
             (Y) holders of equity securities of the Company immediately prior
             to such consummation own, as a group, immediately after such
             consummation, equity securities of the Company (or, if the Company
             does not survive such transaction, voting securities of the
             corporation surviving such transaction) having less than fifty
             percent (50%) of the equity securities of the Company (or such
             other surviving corporation);

       (iii) During any period of two (2) consecutive years, individuals who at
             the beginning of such period constitute the directors of the
             Company cease for any reason other than voluntary resignation,
             death, disability or retirement to constitute at least a majority
             thereof unless the election, or the nomination for election by the
             Company's shareholders, of each new director of the Company was
             approved by a vote of at least two-thirds ( 2/3) of the directors
             of the Company then still in office who were directors of the
             Company at the beginning of any such period; or

        (iv) There shall be consummated any sale, lease, exchange, or other
             transfer (in one transaction or a series of related transactions)
             of assets representing at least 75% of the assets of the Company
             (on a consolidated basis) to a party which is not controlled by or
             under common control with the Company.

        (c)  An option may be exercised at any time or from time to time
(subject, in the case of an incentive stock option, to such restrictions as may
be imposed by the Code), as to any or all full shares of Common Stock as to
which the option has become exercisable. Notwithstanding the foregoing
provision, no option may be exercised without the prior consent of the Committee
by an employee who is subject to Section 16(b) of the Exchange Act until the
expiration of six months from the date of the grant of the option.

        (d)  The purchase price of the shares as to which an option is exercised
shall be paid in full to the Company at the time of exercise; payment may be
made (i) in cash, which may be paid by check, or other instrument acceptable to
the Company; (ii) with the consent of the Committee, and subject to such terms
and conditions as it may determine, by delivery of shares of the Common Stock
which have been owned by the optionee exercising such option for more than six
months (or such longer or shorter period of time required to avoid a charge to
earnings for financial accounting purposes), valued at the Market Value on the
date of exercise, or (iii) at the discretion of the Committee, in accordance
with a cashless exercise program (through broker accommodation), if any,
established by the Committee. In addition, the optionee exercising such option
shall promptly pay to the Company in cash any amount necessary to satisfy all
applicable federal, state or local tax requirements (and in no event shall
Common Stock be delivered with respect to such option until all such amounts
have been fully paid to the Company). The Committee may permit such amount to be
paid in shares of Common Stock previously owned by the optionee for more than
six months prior to such payment (or such longer or shorter period of time
required to avoid a charge to earnings for financial accounting purposes), or a
portion of the shares of Common Stock that otherwise would be distributed to
such optionee upon exercise of the option (PROVIDED, HOWEVER, that the amount of
any Common Stock so withheld shall not exceed the amount necessary to satisfy
the Company's or any Subsidiary's required tax withholding obligations using the
minimum statutory withholding rates for Federal, state, local and foreign tax
purposes, including payroll taxes, that are applicable to supplemental taxable
income), in either case, based on the Market Value of such shares on the date of
payment, as

ICSL STOCK OPTION PLAN                 5

<PAGE>
determined by the Committee, or a combination of cash and shares of such Common
Stock. The Company or a Subsidiary shall, to the extent permitted by law, have
the right to deduct any such taxes from any payment of any kind otherwise due to
such optionee.

        (e)  Except as provided in paragraphs 8, 9 and 10, no options may be
exercised at any time unless the holder thereof is then an employee of or
performing services for the Company or one of its Subsidiaries.

        (f)  Upon, but not until, the exercise of an option or portion thereof
in accordance with the Plan, the applicable option agreement and such rules and
regulations as may be established by the Committee, the holder thereof shall
have the rights of a stockholder with respect to the shares issued as a result
of such exercise.

        (g)  The Company may make loans to such optionees as the Committee, in
its discretion, may determine (including a holder who is a director or officer
of the Company) in connection with the exercise of options granted under the
Plan; PROVIDED, HOWEVER, that the Committee shall not authorize the making of
any loan where the possession of such discretion or the making of such loan
would result in a "modification" (as defined in Section 424 of the Code) of any
incentive stock option. Such loans shall be subject to the following terms and
conditions and such other terms and conditions as the Committee shall determine
not inconsistent with the Plan. Such loans shall bear interest at such rates as
the Committee shall determine from time to time, which rates may be below then
current market rates (except in the case of incentive stock options). In no
event may any such loan exceed the fair market value, at the date of exercise,
of the shares covered by the option, or portion thereof, exercised by the
holder. No loan shall have an initial term exceeding five years, but any such
loan may be renewable at the discretion of the Committee. When a loan shall have
been made, shares of Common Stock having a fair market value at least equal to
the principal amount of the loan shall be pledged by the holder to the Company
as security for payment of the unpaid balance of the loan. Every loan shall
comply with all applicable laws, regulations and rules of the Board of Governors
of the Federal Reserve System and any other governmental agency having
jurisdiction.

    8.  TRANSFERABILITY OF OPTIONS

        (a)  Except as otherwise provided in this paragraph 8, options granted
under the Plan shall not be transferable otherwise than by will or the laws of
descent and distribution, and may be exercised during the lifetime of the
optionee who received such option only by such optionee.

        (b)  No transfer of any options by will or the laws of descent and
distribution shall be effective to bind the Company unless the Committee shall
have been furnished with (i) written notice thereof and with a copy of the will
and/or such evidence as the Committee may deem necessary to establish the
validity of the transfer and (ii) an agreement by the transferee to comply with
all the terms and conditions of the option grant that are or would have been
applicable to the individual to whom the option was granted and to be bound by
the acknowledgments made by such individual in connection with the grant of the
option.

        (c)  With the approval of the Committee and subject to such conditions
as the Committee may prescribe, an optionee may, upon providing written notice
to the Secretary of the Company, elect to transfer any or all such optionee's
non-qualified options to such optionee's spouse, children, grandchildren and the
spouses of children and grandchildren or to trusts for the benefit of the
optionee and/or any of the foregoing family members of the optionee or to
partnerships in which the optionee and/or such family members are the only
partners ("Permitted Transferees"); PROVIDED, HOWEVER, that no such transfer by
any optionee may be made in exchange for consideration and following any such
transfer the option may not be subsequently transferred; and PROVIDED FURTHER,
HOWEVER, that following any such transfer, the exercise, vesting and termination
provisions of such option and the Plan shall continue to be applied with respect
to the optionee who transferred such option.

ICSL STOCK OPTION PLAN                 6

<PAGE>
        (d)  If any rights exercisable by the optionee or benefits deliverable
to an optionee under the Plan have not been exercised or delivered,
respectively, at the time of the optionee's death, such rights shall be
exercisable by the optionee's Designated Beneficiary, and such benefits shall be
delivered to the Designated Beneficiary, in accordance with the provisions of
the Plan and the applicable option agreement. The "Designated Beneficiary" shall
be the beneficiary or beneficiaries designated by the optionee in a writing
filed with the Committee in such form and at such time as the Committee shall
require. If a deceased optionee fails to designate a beneficiary, or if the
Designated Beneficiary does not survive the optionee, any rights that would have
been exercisable by the optionee and any benefits distributable to the optionee
shall be exercised by or distributed to the legal representative of the estate
of the optionee. If a deceased optionee designates a beneficiary but the
Designated Beneficiary dies before the Designated Beneficiary's exercise of all
rights under the Plan or the option agreement or before the complete
distribution of benefits to the Designated Beneficiary under the option
agreement, then any rights that would have been exercisable by the Designated
Beneficiary shall be exercised by the legal representative of the estate of the
Designated Beneficiary, and any benefits distributable to the Designated
Beneficiary shall be distributed to the legal representative of the estate of
the Designated Beneficiary.

    9.  TERMINATION OF SERVICE

        (a)  Unless otherwise determined by the Committee and stated in the
option agreement, and subject to such restrictions as may be imposed by the Code
in the case of any incentive stock options, in the event that the employment or
other period of service with the Company and the Subsidiaries of an optionee to
whom an option has been granted under the Plan shall be terminated (except as
set forth in paragraph 10), such option may, subject to the provisions of the
Plan, be exercised (to the extent that the optionee was entitled to do so under
the Plan and the optionee's option agreement at the termination of his
employment or period of service) at any time within three months after such
termination, or, in the case of an employee whose termination results from
retirement from active employment at or after age 55 (as determined by the
Committee in its good faith discretion) within one year after such termination,
but in no case later than the date on which the option expires; PROVIDED,
HOWEVER, that any option held by an employee or consultant whose employment or
service with the Company or a Subsidiary is terminated for cause (as determined
by the Committee in its good faith discretion) shall forthwith terminate, to the
extent not theretofore exercised.

        (b)  Options granted under the Plan shall not be affected by any change
of duties or position so long as the optionee holding any such option continues
to be an employee, director or consultant of the Company or any of its
Subsidiaries, subject to any applicable limitations on the holding of incentive
stock options. Any option agreement, or any rules and regulations relating to
the Plan, may contain such provisions as the Committee shall approve with
reference to the determination of the date employment or period of service with
the Company and any Subsidiary terminates and the effect of leaves of absence.
Any such rules and regulations with reference to any option agreement shall be
consistent with the provisions of the Code and any applicable rules and
regulations thereunder.

        (c)  Nothing in the Plan or in any option granted pursuant to the Plan
shall confer upon any employee, director or consultant any right to continue in
the employ of, or in any other relationship with, the Company or any of its
Subsidiaries or interfere in any way with the right of the Company or any such
Subsidiary to terminate any such employment or other relationship at any time.

    10.  DEATH OR TOTAL DISABILITY OF OPTIONEE

    If an optionee ceases to be an employee, director or consultant of the
Company or any Subsidiary by reason of "total disability," such optionee's
option may be exercised, to the extent that the optionee or a Permitted
Transferee of the option was entitled to do so at the termination of employment
or service with the Company or such a Subsidiary, as set forth herein and in the
optionee's option agreement (subject to the restrictions set forth in
paragraph 7 or otherwise applicable with respect to persons subject to

ICSL STOCK OPTION PLAN                 7

<PAGE>
Section 16(b) of the Exchange Act) at any time within one year after the date of
such termination of employment or service, but in no case later than the date on
which the option expires. If an optionee shall die while an employee, director
or consultant of the Company or its Subsidiaries or within three months (or, in
the case of an employee whose termination results from disability or retirement
from active employment at or after age 55, within one year) after the
termination of such employment or other relationship with the Company or such a
Subsidiary (other than termination for cause), such optionee's option may be
exercised, to the extent that the optionee or a Permitted Transferee of the
option was entitled to do so at the termination of employment or service with
the Company or such as Subsidiary (or at the date of death, if later), as set
forth herein and in the optionee's option agreement by the optionee, a legatee
or legatees of the optionee under the optionee's last will, by the optionee's
personal representatives or distributees or by the Permitted Transferee,
whichever is applicable, at any time within one year after the date of the
optionee's death, but in no case later than the date on which the option
expires. For purposes hereof, "total disability" is defined as the permanent
inability of an optionee, as a result of accident or sickness, to perform any
and every duty pertaining to such optionee's occupation or employment for which
the optionee is suited by reason of the optionee's previous training, education
and experience, as determined by the Committee in its good faith discretion,
and, for purposes of incentive stock options granted under the plan, "total
disability" shall mean "permanent and total disability," as defined in
Section 22(e)(3) of the Code.

    11.  ADJUSTMENT UPON CHANGES IN CAPITALIZATION, ETC.

        (a)  Notwithstanding any other provision of the Plan, in the event of
distributions to holders of Common Stock other than a normal cash dividend,
changes in the outstanding Common Stock by reason of stock dividends, split-ups,
recapitalizations, mergers, consolidations, combinations or exchanges of shares,
separations, reorganizations, liquidations, "spin-offs" or similar capital
changes, the Committee may, in its sole discretion, make such adjustments to the
number, class and kind of shares available under the Plan and to the number,
class, kind and price of shares available under any outstanding option as it may
deem appropriate to prevent dilution or enlargement of the rights of optionees
or otherwise to reflect such capital changes. Any such determination by the
Committee shall be conclusive. No adjustment shall be made in respect of an
incentive stock option if such adjustment would disqualify such option as an
incentive stock option under Section 422 of the Code and the Treasury
Regulations thereunder, unless the Committee determines otherwise. No adjustment
shall be made in the minimum number of shares with respect to which an option
may be exercised at any time. Any fractional shares resulting from such
adjustments to options shall be eliminated.

        (b)  In the event of a Change of Control, in addition to or in lieu of
the any acceleration of outstanding options described in paragraph 7(b):

        (i) In its discretion, and on such terms and conditions as it deems
            appropriate, the Committee may provide, either by the terms of the
            option agreement applicable to any option or by resolution adopted
            prior to the occurrence of the Change of Control, that any
            outstanding option shall be adjusted by substituting for Common
            Stock subject to such option stock or other securities of the
            surviving corporation or any successor corporation to the Company,
            or a parent or subsidiary thereof, or that may be issuable by
            another corporation that is a party to the transaction resulting in
            the Change of Control, whether or not such stock or other securities
            are publicly traded, in which event the aggregate option exercise
            price shall remain the same and the amount of shares or other
            securities subject to the option shall be the amount of shares or
            other securities which could have been purchased on the closing date
            or expiration date of such transaction with the proceeds which would
            have been received by the optionee if the option had been exercised
            in full (or with respect to a portion of such option, as determined
            by the Committee, in its discretion) prior to such transaction or
            expiration date and the optionee exchanged all of such shares in the
            transaction.

ICSL STOCK OPTION PLAN                 8

<PAGE>
        (ii) In its discretion, and on such terms and conditions as it deems
             appropriate, the Committee may provide, either by the terms of the
             option agreement applicable to any option or by resolution adopted
             prior to the occurrence of the Change of Control, that any
             outstanding option shall be converted into a right to receive cash
             on or following the closing date or expiration date of the
             transaction resulting in the Change of Control in an amount equal
             to the highest value of the consideration to be received in
             connection with such transaction for one share of Common Stock,
             less the per share option exercise price of such option, multiplied
             by the number of shares of Common Stock subject to such option, or
             a portion thereof.

       (iii) The Committee may, in its discretion, provide that an option cannot
             be exercised after such a Change of Control, to the extent that
             such option is or becomes fully exercisable on or before such
             Change of Control and/or is subject to any acceleration, adjustment
             or conversion in accordance with paragraph 7(b) or the foregoing
             subparagraphs (i) or (ii) of this paragraph 11(b).

No optionee shall have any right to prevent the consummation of any of the
foregoing acts affecting the number of shares of Common Stock available to such
optionee. Any actions or determinations of the Committee under this
paragraph 11(b) or paragraph 7(b) need not be uniform as to all outstanding
options, nor treat all optionees identically. Notwithstanding the foregoing
adjustments, in no event may any option be exercised after ten (10) years from
the date it was originally granted.

    12.  EFFECTIVE DATE; COMPLIANCE WITH LAW; OPTIONEE ACKNOWLEDGMENTS

        (a)  The Plan shall be effective as of (a) the "Effective Date" set
forth in the Company's prepackaged plan of reorganization filed pursuant to
Chapter 11 of the United States Bankruptcy Code (the "Prepackaged Plan")
provided that such Prepackaged Plan shall be approved and confirmed by the
bankruptcy court having jurisdiction over the Prepackaged Plan, or (b) in the
event the Prepackaged Plan is not approved and confirmed by such bankruptcy
court, the date on which the Plan is approved by the stockholders of the
Company, which approval shall occur within twelve (12) months before or after
the date the Plan is adopted by the Board of Directors. The Committee thereafter
may, in its discretion, grant options under the Plan, the grant, exercise or
payment of which shall be expressly subject to the conditions that, to the
extent required at the time of grant, exercise or payment, (i) if the Company
deems it necessary or desirable, a Registration Statement under the Securities
Act of 1933, as amended (the "Securities Act"), with respect to such shares
shall be effective, and (ii) any requisite approval or consent of any
governmental authority of any kind having jurisdiction over options granted
under the Plan shall have been obtained.

        (b)  If at any time counsel to the Company shall be of the opinion that
any sale or delivery of shares of Common Stock pursuant to an option under the
Plan is or may be in the circumstance unlawful or result in the imposition of
excise taxes on the Company or any Subsidiary under the statutes, rules or
regulations of any applicable jurisdiction, the Company shall have no obligation
to make such sale or delivery, or to make any application or to effect or to
maintain any qualification or registration under the Securities Act, or
otherwise with respect to shares of Common Stock or option grants under the Plan
and the right to exercise any option shall be suspended until, in the opinion of
such counsel, such sale or delivery shall be lawful or will not result in the
imposition of excise taxes on the Company or any Subsidiary.

        (c)  The Committee may require each person receiving Common Stock in
connection with an award under the Plan to represent and agree with the Company
in writing that such person is acquiring the shares of Common Stock for
investment without a view to the distribution thereof. The Committee, in its
absolute discretion, may impose such restrictions on the ownership and
transferability of shares of Common Stock purchasable or otherwise receivable by
any person under any award as it deems appropriate. Any such restrictions shall
be set forth in the applicable option agreement, and the certificates

ICSL STOCK OPTION PLAN                 9

<PAGE>
evidencing such shares may include any legend that the Committee deems
appropriate to reflect any such restrictions. The Committee may require an
optionee to give prompt written notice to the Company concerning any disposition
of shares of Common Stock received upon the exercise of an incentive stock
option within: (i) two (2) years from the date of granting such incentive stock
option to such optionee or (ii) one (1) year from the transfer of such shares of
Common Stock to such optionee or (iii) such other period as the Committee may
from time to time determine. The Committee may direct that an optionee undertake
in the applicable option agreement to give such notice described in the
preceding sentence, at such time and containing such information as the
Committee may prescribe, and/or that the certificates evidencing shares of
Common Stock acquired by exercise of an incentive stock option refer to such
requirement to give such notice.

        (d)  By accepting any benefit under the Plan, each optionee and each
person claiming under or through such optionee shall be conclusively deemed to
have indicated their acceptance and ratification of, and consent to, all of the
terms and conditions of the Plan and any action taken under the Plan by the
Committee, the Company or the Board of Directors, in any case in accordance with
the terms and conditions of the Plan.

    13.  TERMINATION AND AMENDMENT

    The Plan shall be of unlimited duration; PROVIDED, HOWEVER, that, to the
extent required by the Code, no incentive stock option may be granted under the
Plan on a date that is more than ten (10) years from the effective date of the
Plan set forth in Section 12. The Board of Directors may suspend, terminate,
modify or amend the Plan, PROVIDED that any modification or amendment that would
(a) increase the aggregate number of shares that may be issued under the Plan or
the limitations set forth in paragraph 4(c) on the maximum number of shares of
Common Stock that may be subject to options granted to a single optionee;
(b) decrease the minimum option exercise price requirements of paragraph 5 or
otherwise materially increase the benefits accruing to optionees under the Plan;
(c) extend the duration of the period during which incentive stock options may
be granted under the Plan or the period during which options may be exercised
under paragraph 6; or (d) modify the requirements as to eligibility for
participation in the Plan shall be subject to the approval of the Company's
stockholders, except that any such increase in shares of Common Stock or
decrease in option exercise price that may result from adjustments authorized by
paragraph 11 does not require such approval. If the Plan is terminated, the
terms of the Plan shall, notwithstanding such termination, continue to apply to
awards granted prior to such termination. In addition, no suspension,
termination, modification or amendment of the Plan, other than as may result
from adjustments authorized by paragraph 11, may, without the consent of the
optionee to whom an option shall theretofore have been granted, materially
adversely affect the rights of such optionee under such option. The Committee
may amend the terms of any option theretofore granted under the Plan, including
any agreement evidencing any such option, retroactively or prospectively, but no
such amendment, other than as may result from adjustments authorized by
paragraph 11, shall materially impair the previously accrued right of any
optionee under any outstanding option without his or her written consent.

    14.  WRITTEN AGREEMENTS

    Each grant of options shall be evidenced by a written agreement, executed by
the optionee and the Company, which shall contain such restrictions, terms and
conditions, not inconsistent with the terms and conditions of the Plan, as the
Committee may require. Each such option agreement shall state whether such
option will be treated as an incentive stock option or non-qualified option.

    15.  EFFECT ON OTHER STOCK PLANS; GOVERNING LAW

        (a)  The adoption of the Plan shall have no effect on option grants made
or to be made, pursuant to other stock plans or otherwise, to employees,
directors or consultants of the Company or its Subsidiaries, or any predecessors
or successors thereto.

ICSL STOCK OPTION PLAN                 10

<PAGE>
        (b)  The Plan shall be governed by and construed in accordance with the
laws of the State of Delaware, without regard to such state's conflict of law
provisions, and, in any event, except as superseded by applicable Federal law.

    IN WITNESS WHEREOF, the Company has caused its duly authorized officer to
execute this Plan as of the 21st day of September 2000.

                                 INNOVATIVE CLINICAL SOLUTIONS, LTD.

                                 By: /s/ Michael T. Heffernan
                                 --------------------------------------------

                                 Title: President and Chief Executive Officer
                                 --------------------------------------------

ICSL STOCK OPTION PLAN                 11
<PAGE>
                                                                      SCHEDULE I

      EMPLOYEES AND DIRECTORS DESIGNATED TO RECEIVE INITIAL OPTION GRANTS
        UNDER INNOVATIVE CLINICAL SOLUTIONS, LTD. 2000 STOCK OPTION PLAN

<TABLE>
<CAPTION>
EMPLOYEE                                                      SHARES COVERED BY OPTION
--------                                                      ------------------------
<S>                                                           <C>
Michael T. Heffernan........................................          357,143
Bryan B. Dieter.............................................          357,143
Gary S. Gillheeney..........................................          357,143
R. Adrian Otte, M.D.........................................          457,143
John Wardle.................................................          357,143

DIRECTOR
--------
William S. Bernstein........................................           28,571
David M. Livingston.........................................           28,571
Kevin E. Moley..............................................           28,571
Marvin Moser, M.D...........................................           28,571
Eric Moskow, M.D............................................           28,571

Shares not subject to Options granted
  pursuant to paragraph 4(d) or 4(e)
  ("Unallocated Options")...................................          257,144
</TABLE>

                                       12<PAGE>

                                                                    EXHIBIT 10.2

================================================================================

                          REGISTRATION RIGHTS AGREEMENT

                         Dated as of September 21, 2000

                                  by and among

                       INNOVATIVE CLINICAL SOLUTIONS, LTD.

                                       and

                    EACH SECURITIES HOLDER REFERRED TO HEREIN

================================================================================

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                               PAGE

<S>                                                                                                            <C>
Section 1.  Definitions...........................................................................................1

         1.1.  Defined Terms......................................................................................1

Section 2.  Demand Registration Rights of Securities Holders......................................................5

         2.1.  Demand Registration Rights.........................................................................5
         2.2.  Determination......................................................................................6
         2.3.  Notices; Minimum Registerable Amounts..............................................................6
         2.4.  Discretion of Securities Holder....................................................................7
         2.5.  Allocation Among Initiating Securities Holders.....................................................7
         2.6.  Piggyback Rights of Securities Holders and the Company.............................................8

Section 3.  Company Sale Events...................................................................................9

         3.1.  Determination......................................................................................9
         3.2.  Notice.............................................................................................9
         3.3.  Piggyback Rights of Securities Holders.............................................................9
         3.4.  Discretion of the Company..........................................................................9

Section 4.  Black-Out Periods....................................................................................10

         4.1.  Black-Out Periods for Securities Holders..........................................................10

Section 5.  Agreements Concerning Offerings......................................................................10

         5.1.  Obligations of Securities Holders.................................................................10
         5.2.  Obligations of the Company........................................................................10
         5.3.  Agreements Related to Offerings...................................................................12
         5.4.  Certain Expenses..................................................................................14
         5.5.  Reports Under the Exchange Act; Rule 144..........................................................14
         5.6.  Limitations on Subsequent Registration Rights.....................................................15
         5.7.  Indemnification and Contribution..................................................................15
         5.8.  Underwritten Offerings............................................................................22
         5.9.  Transfer of Rights Under this Agreement; Transfers of Registerable Common.........................22
         5.10.  Termination of Rights............................................................................22

Section 6.  Sequencing of Public Sale Events.....................................................................22

         6.1.  Effective Notice Period...........................................................................22
         6.2.  Restrictive Legend on Certificates................................................................23

Section 7.  Representations and Warranties of the Company........................................................24

<PAGE>

Section 8.  Representations and Warranties of the Securities Holders.............................................27

Section 9.  Delivery of Comfort Letter and Legal Opinion.........................................................29

Section 10.  Miscellaneous.......................................................................................29

         10.1.  Notices..........................................................................................29
         10.2.  Amendments and Waivers...........................................................................29
         10.3.  Termination......................................................................................30
         10.4.  Survival of Representations and Warranties.......................................................30
         10.5.  Headings.........................................................................................30
         10.6.  Counterparts.....................................................................................30
         10.7.  GOVERNING LAW....................................................................................30
         10.8.  Adjustment of Shares.............................................................................30
         10.9.  No Inconsistent Agreements.......................................................................30
         10.10.  Severability....................................................................................31
         10.11.  ENTIRE AGREEMENT................................................................................31
         10.12.  Listing of New Common Stock.....................................................................31

         SCHEDULES

                  Schedule 1 - Registrable Common As of the Effective Date

         EXHIBITS

                  Exhibit A - Securities Holders Questionnaire

                  Exhibit B - Supplemental Addendum
</TABLE>

<PAGE>

                          REGISTRATION RIGHTS AGREEMENT

                REGISTRATION RIGHTS AGREEMENT, dated as of September 21, 2000,
by and among INNOVATIVE CLINICAL SOLUTIONS, LTD., a corporation organized under
the laws of the State of Delaware (the "COMPANY"), and each SECURITIES HOLDER
(as defined in subsection 1.1).

                              W I T N E S S E T H:

                WHEREAS, in connection with the restructuring of the Company's 6
3/4% Convertible Subordinated Debentures due 2003 (the "Debentures"), shares of
New Common Stock (as defined below) are being issued to holders of the
Debentures; and

                WHEREAS, the Company and the Securities Holders have agreed that
the Company shall provide registration rights to such Holders on the terms
herein set forth.

                NOW, THEREFORE, in consideration of the mutual agreements
contained herein, the parties hereto hereby agree as follows:

                  Section 1.  DEFINITIONS.

                  1.1. DEFINED TERMS. (a) As used in this Agreement, the terms
defined in the caption and the recitals shall have the meanings set forth
therein, and the following terms shall have the following meanings:

                  "AFFILIATE" shall have the meaning ascribed thereto in Rule
         12b-2 under the Exchange Act as in effect on the date hereof.

                  "AGREEMENT" shall mean this Registration Rights Agreement, as
         amended, supplemented or otherwise modified from time to time.

                  "COMMISSION" shall mean the United States Securities and
         Exchange Commission or any successor thereto.

                  "COMPANY PUBLIC SALE EVENT" shall mean any sale by the
         Company of New Common Stock pursuant to a Registration Statement filed
         by the Company (other than a Registration Statement filed by the
         Company on either Form S-4 or Form S-8) pursuant to subsection 3.1.

                  "COMPANY SALE NOTICE" shall mean a Notice of Offering from the
         Company to each Security Holder stating that the Company proposes to
         effect a Company Public Sale Event.

<PAGE>

                  "DEMAND REGISTRATION" shall mean any Registration of
         Registerable Common pursuant to a Registration Statement filed by the
         Company in accordance with the provisions of subsection 2.2.

                  "EFFECTIVE DATE" shall mean September __, 2000, the date on
         which New Common Stock is exchanged for Notes then held by the
         Securities Holders.

                  "EFFECTIVE NOTICE PERIOD" shall have the meaning assigned to
such term in subsection 6.1.

                  "ESQF" shall mean ESQF Advisors, Inc.

                  "EXCHANGE ACT" shall mean the Securities Exchange Act of 1934,
         as amended, or any successor legislation thereto.

                  "FORM S-1" shall mean such form of registration statement
         under the Securities Act as in effect on the date hereof or any
         successor form thereto.

                  "FORM S-3" shall mean such form of registration statement
         under the Securities Act as in effect on the date hereof or any
         successor form thereto.

                  "FORM S-4" shall mean such form of registration statement
         under the Securities Act as in effect on the date hereof or any
         successor form thereto.

                  "FORM S-8" shall mean such form of registration statement
         under the Securities Act as in effect on the date hereof or any
         successor form thereto.

                  "GOVERNMENTAL AUTHORITY" shall mean any nation or government,
         any state or other political subdivision thereof or any entity
         exercising executive, legislative, judicial, regulatory or
         administrative functions of or pertaining to government.

                  "ICSL GROUP" shall mean the Company and each of its
         Subsidiaries.

                  "INITIATING SECURITIES HOLDERS" shall have the meaning
         assigned to such term in subsection 2.3(b).

                  "MATERIAL ADVERSE CHANGE" shall mean, for purposes of
         subsections 2.4(b) and (c), any material adverse change in, or the
         occurrence of any event which would reasonably be expected to have a
         material adverse effect on, the business, condition (financial or
         otherwise) or prospects of the ICSL Group taken as a whole (it being
         understood that a change in general political, financial, banking or
         capital market conditions shall not be a "Material Adverse Change"
         unless such change has, or would reasonably be expected to have, a
         material adverse effect on the ICSL Group as described above).

                  "MINIMUM REGISTERABLE AMOUNT" shall mean, on any date of
         determination thereof, (i) in the case of a Demand Registration other
         than a Shelf Registration, 5% of the issued and then outstanding shares
         of New Common Stock or (ii) in the case of a

                                      -2-

<PAGE>

         Shelf Registration, 10% of the issued and then outstanding shares of
         New Common Stock.

                  "NASD" shall mean the National Association of Securities
         Dealers, Inc. or any successor thereto.

                  "NEW COMMON STOCK" shall mean the common stock, par value $.01
         per share, of the Company and any reclassification thereof.

                  "NOTICE OF OFFERING" shall mean a written notice with respect
         to (a) a proposed Sale Event pursuant to a Demand Registration or (b) a
         Company Public Sale Event, in each case setting forth (i) the expected
         maximum and minimum number of shares of Registerable Common or New
         Common Stock, as the case may be, proposed to be offered and sold, (ii)
         the lead managing underwriter, if applicable and known and (iii) the
         proposed method of distribution and the expected timing of the
         offering.

                  "PERSON" shall mean any individual, partnership, corporation,
         business trust, joint stock company, trust, unincorporated association,
         joint venture, Governmental Authority, limited liability company or
         other entity of whatever nature.

                  "PIGGYBACKING NOTICE" shall have the meaning assigned to such
         term in subsection 2.6(a).

                  "PIGGYBACKING SECURITIES HOLDER" shall have the meaning
         assigned to such term in subsection 2.6(a).

                  "PRELIMINARY PROSPECTUS" shall mean each preliminary
         prospectus included in a Registration Statement or in any amendment
         thereto prior to the date on which such Registration Statement is
         declared effective under the Securities Act, including any prospectus
         filed with the Commission pursuant to Rule 424(a) under the Securities
         Act.

                  "PROSPECTUS" shall mean each prospectus included in a
         Registration Statement (including, without limitation, a prospectus
         that discloses information previously omitted from a prospectus filed
         as part of an effective Registration Statement in accordance with Rule
         430A), together with any supplement thereto, as filed with, or
         transmitted for filing to, the Commission pursuant to Rule 424(b) under
         the Securities Act.

                  "PUBLIC SALE EVENT" shall mean a Securities Holder Public Sale
         Event or a Company Public Sale Event, as the case may be.

                  "PURCHASE AGREEMENT" shall mean, in connection with any Sale
         Event, any written agreement entered into by any Securities Holder
         providing for the sale of Registerable Common and/or the Company
         providing for the sale of New Common Stock.

                  "REGISTERABLE COMMON" shall mean with respect to each
         Securities Holder (a) the shares of New Common Stock issued to such
         Securities Holder in exchange for its Debentures (in the number, as of
         the Effective Date, as set forth on Schedule 1 hereto), and (b) any
         other securities issued as (or issuable upon the conversion or exercise
         of any

                                      -3-

<PAGE>

         warrant, right or other security which is issued as) a dividend
         or other distribution with respect to, or in exchange for or in
         replacement of, such shares of Registerable Common; excluding in all
         cases, however, any shares of Registerable Common from and after the
         transfer thereof pursuant to a Registration Statement or Rule 144.

                  "REGISTRATION" shall mean a registration of securities
         pursuant to the Securities Act.

                  "REGISTRATION STATEMENT" shall mean any registration statement
         (including the Preliminary Prospectus, the Prospectus, any amendments
         (including any post-effective amendments) thereof, any supplements and
         all exhibits thereto and any documents incorporated therein by
         reference pursuant to the rules and regulations of the Commission),
         filed by the Company with the Commission which complies with the
         requirements of the Securities Act and the rules and regulations of the
         Commission thereunder in connection with any Public Sale Event.

                  "RESPONSIBLE OFFICER" shall mean with respect to any Person,
         the president, chief executive officer, chief operating officer, chief
         financial officer, vice president-finance or treasurer of such Person.

                  "RULE 144", shall mean Rule 144 promulgated by the Commission
         under the Securities Act, or any successor to such Rule.

                  "RULE 415" shall mean Rule 415 promulgated by the Commission
         under the Securities Act, or any successor to such Rule.

                  "RULE 424" shall mean Rule 424 promulgated by the Commission
         under the Securities Act, or any successor to such Rule.

                  "RULE 430A" shall mean Rule 430A promulgated by the Commission
         under the Securities Act, or any successor to such Rule.

                  "SALE EVENT" shall mean any sale by the Company of New Common
         Stock pursuant to a Company Public Sale Event or any sale by any
         Securities Holder of Registerable Common pursuant to any Registration
         Statement.

                  "SECURITIES ACT" shall mean the Securities Act of 1933, as
         amended, or any successor legislation thereto.

                  "SECURITIES HOLDER" shall mean each entity set forth on the
         signature pages of this Agreement under the heading "SECURITIES
         HOLDERS", including any transferee who becomes bound by the terms of
         this Agreement pursuant to Section 5.9.

                  "SECURITIES HOLDER PUBLIC SALE EVENT" shall mean any sale of
         Registerable Common by a Securities Holder pursuant to a Demand
         Registration.

                  "SECURITIES HOLDER SALE NOTICE" shall mean a Notice of
         Offering to the Company from a Securities Holder requesting the Company
         to effect a Demand Registration of

                                      -4-

<PAGE>

         Registerable Common (to which such Securities Holder is at the time
         entitled pursuant to subsection 2.1) and stating whether such
         Securities Holder is requesting that such Demand Registration be a
         Shelf Registration; PROVIDED that if more than one Notice of Offering
         is required to aggregate the Minimum Registerable Amount, the term
         "Securities Holder Sale Notice" shall refer collectively to all such
         Notices of Offering delivered by Securities Holders to the Company in
         accordance with subsection 2.3(b).

                  "SECURITIES HOLDER'S QUESTIONNAIRE" shall mean the
         questionnaire to be provided by each Securities Holder to the Company
         in connection with a Public Sale Event, substantially in the form of
         Exhibit A, as the same from time to time may be amended, supplemented
         or otherwise modified.

                  "SHELF REGISTRATION" shall mean any Registration of
         Registerable Common pursuant to a Registration Statement filed by the
         Company in accordance with the provisions of subsection 2.2 and which
         provides for the offering of Registerable Common to be made on a
         continuous basis pursuant to Rule 415.

                  "SUBSIDIARY" " shall mean, as to any Person, a corporation,
         partnership or other entity of which shares of stock or other ownership
         interests having ordinary voting power (other than stock or such other
         ownership interests having such power only by reason of the happening
         of a contingency) to elect the majority of the board of directors or
         other managers of such corporation, partnership or other entity are at
         that time owned directly or indirectly through one or more
         intermediaries, or both, by such Person. Unless otherwise qualified,
         all references to a "Subsidiary" or "Subsidiaries" in this Agreement
         shall refer to a Subsidiary or Subsidiaries of the Company.

                  "SUPPLEMENTAL ADDENDUM" shall mean a Supplemental Addendum,
         substantially in the form of Exhibit B to this Agreement.

                  "TERMINATION DATE" shall mean, as to each Securities Holder,
         the date on which counsel to the Company delivers an opinion in
         accordance with subsection 5.10 to such Securities Holder.

                (b) The words "hereof", "herein" and "hereunder" and words of
similar import when used in this Agreement shall refer to this Agreement as a
whole and not to any particular provision of this Agreement, and section,
subsection, schedule and exhibit references are to this Agreement.

                  Section 2.  DEMAND REGISTRATION RIGHTS OF SECURITIES HOLDERS.

                  2.1. DEMAND REGISTRATION RIGHTS. At any time prior to the
Termination Date, each Securities Holder shall have the right, subject to
subsections 2.3 and 6.1, to request an unlimited number of Demand Registrations,
and the Company shall be obligated to provide a Demand Registration in response
to each such request.

                  2.2. DETERMINATION. Subject to the terms and conditions
hereof, if the Company shall at any time receive a Securities Holder Sale Notice
in accordance with subsection 2.3 representing at least the Minimum Registerable
Amount, then the Company shall (a) (i) in the

                                      -5-

<PAGE>

case of a Registration Statement on Form S-1, use its reasonable best efforts to
file such Registration Statement within 45 days, and in any event, but subject
to subsection 5.3(b), make such filing within 75 days, of the receipt of such
Securities Holder Sale Notice or (ii) in the case of a Registration Statement on
Form S-3, use its reasonable best efforts to file such Registration Statement
within 30 days, and in any event, but subject to subsection 5.3(b), make such
filing within 60 days (PROVIDED that such time periods shall begin on the date
of the Company's receipt of the Securities Holder Sale Notice which, together
with any earlier delivered Securities Holder Sale Notice, represents the
applicable Minimum Registerable Amount), which Registration Statement shall
cover the maximum number of shares of Registerable Common set forth in such
Securities Holder Sale Notice, and, if applicable, such additional shares of New
Common Stock as permitted under subsection 2.6 and (b) use its best efforts to
facilitate such Demand Registration as provided herein. Notwithstanding the
foregoing, the Company may delay the filing of (but not its obligation to
expeditiously prepare) any Registration Statement relating to a Demand
Registration for a reasonable period of time (not in excess of 90 days) if the
Board of Directors of the Company reasonably determines to delay such filing
and, within ten (10) days of such determination, the Company provides each
Securities Holder that delivered a Securities Holder Sale Notice with a
certificate signed by the Chairman of the Board of Directors of the Company or
the Chief Executive Officer of the Company stating that, in the good faith
judgment of the Board of Directors of the Company, the filing of such
Registration Statement would adversely affect any material business situation,
transaction or negotiation then contemplated by the Company or materially and
adversely affect the Company. The Company shall promptly give notice to each
such Securities Holder of the end of any delay period under this subsection.
Subject to any extension under subsection 4.1(b), the Company shall keep any
Demand Registration Statement effective for a period of (i) in the case of a
Demand Registration other than a Shelf Registration, until the earlier of (x)
the four (4) month anniversary of the date that the Registration Statement with
respect thereto is declared effective by the Commission and (y) the date on
which all of the Registerable Common covered by such Registration Statement has
been sold and (ii) in the case of a Shelf Registration, until the earlier of (x)
two (2) years following the date the Registration Statement with respect thereto
is declared effective by the Commission and (y) the date on which all of the
Registerable Common covered by such Registration Statement has been sold or, in
each case, such shorter period if any such Registration is terminated in
accordance with the terms hereof prior to the end of the applicable period.

                  2.3. NOTICES; MINIMUM REGISTERABLE AMOUNTS. (a) Subject to
subsection 2.1, any Securities Holder may send a Securities Holder Sale Notice
to the Company in respect of a Demand Registration. Simultaneously with the
delivery to the Company of a Securities Holder Sale Notice, the Securities
Holder so requesting a Demand Registration shall deliver to each other
Securities Holder a copy of such Securities Holder Sale Notice and such other
information as such Securities Holder may deem appropriate.

                  (b) Notwithstanding subsection 2.3(a), no Securities Holder
Sale Notice delivered by a Securities Holder shall be effective to require the
Company to provide a Demand Registration, unless (i) the aggregate number of
shares of New Common Stock represented by such Securities Holder Sale Notice
equals or exceeds the Minimum Registerable Amount or (ii) within twenty (20)
days of the delivery of the first Securities Holder Sale Notice in respect of an
aggregate number of shares of New Common Stock that does not equal or exceed the
Minimum

                                      -6-

<PAGE>

Registerable Amount one or more additional Securities Holder Sale Notices are
delivered by Securities Holders then entitled to request a Demand Registration
pursuant to subsection 2.1(a) such that the aggregate number of shares of New
Common Stock represented by all such Securities Holder Sale Notices (including
the Securities Holder Sale Notice which commenced such twenty (20) day period)
is at least equal to the Minimum Registerable Amount. All Securities Holders
delivering Securities Holder Sale Notices in accordance with the immediately
preceding sentence are hereinafter referred to as the "Initiating Securities
Holders". Subject to subsection 2.4, the delivery of any Securities Holder Sale
Notice pursuant to this subsection 2.3(b), shall be deemed a request by each
Initiating Securities Holder under subsection 2.1 for a Demand Registration,
PROVIDED that if all Securities Holder Sale Notices so delivered do not
represent at least the Minimum Registerable Amount, then all such Securities
Holder Sale Notices shall be deemed null and void and shall not constitute a
request for Demand Registration under subsection 2.1 by any Initiating
Securities Holder.

                  (c) Any Securities Holder Sale Notice may be revised from time
to time prior to the earlier of (i) the execution of the Purchase Agreement, if
any, for such offering and (ii) the effectiveness of the Registration Statement
for such offering; PROVIDED that in no event may a Securities Holder Sale Notice
be revised so as to reduce the aggregate number of shares of New Common Stock
represented by such Securities Holder Sale Notice below the Minimum Registerable
Amount.

                  (d) The Company shall promptly provide a Securities Holder
Questionnaire (i) in the case of a Demand Registration, to each Securities
Holder that delivers a Securities Holder Sale Notice in accordance with this
subsection 2.3 and each Piggybacking Securities Holder and (ii) in the case of a
Company Public Sale Event, to each Securities Holder that has indicated its
desire pursuant to subsection 3.3 to participate in such Sale Event.

                  2.4. DISCRETION OF SECURITIES HOLDER. In connection with any
Securities Holder Public Sale Event, subject to the provisions of this
Agreement, the Securities Holder requesting a Demand Registration (if such
Public Sale Event was initiated by an individual Securities Holder) or the
Initiating Securities Holders owning a majority of the aggregate number of
shares of Registerable Common that all such Initiating Securities Holders are
seeking to include in such Public Sale Event (if such Public Sale Event was
initiated by Initiating Securities Holders), in its or their sole discretion, as
the case may be, shall determine whether (i) to proceed with, withdraw from or
terminate such proposed Securities Holder Public Sale Event, (ii) to enter into
one or more Purchase Agreements for such Securities Holder Public Sale Event and
(iii) to take such actions as may be necessary to close the sale of Registerable
Common contemplated by such offering, including, without limitation, waiving any
conditions to closing such sale which have not been fulfilled.

                  2.5. ALLOCATION AMONG INITIATING SECURITIES HOLDERS. In
connection with any Demand Registration requested by Initiating Securities
Holders in accordance with subsection 2.3, if the lead managing underwriter
selected by such Initiating Securities Holders in accordance with subsection 5.8
with respect to such offering (or, if the offering is not underwritten, if a
financial advisor to such Initiating Securities Holders) determines that
marketing factors require a limitation on the number of shares of Registerable
Common to be offered and sold in such offering, there shall be included in the
offering only that number of shares of Registerable

                                      -7-

<PAGE>

Common that such lead managing underwriter or financial advisor, as the case may
be, reasonably and in good faith believes will not jeopardize the success of the
offering, which shares of Registerable Common shall be allocated among the
Initiating Securities Holders on a PRO RATA basis based on the number of shares
of Registerable Common each such Initiating Securities Holder seeks to include
in such offering.

                  2.6. PIGGYBACK RIGHTS OF SECURITIES HOLDERS AND THE COMPANY.
(a) In connection with any Demand Registration that has been requested by a
Securities Holder or Initiating Securities Holders, as the case may be, in
accordance with subsections 2.1 and 2.3, any other Securities Holder then
holding Registerable Common (a "PIGGYBACKING SECURITIES HOLDER") and the Company
shall be entitled, subject to subsection 2.6(b), to participate on the same
terms and conditions as such Securities Holder in the Securities Holder Public
Sale Event relating thereto and offer and sell shares of Registerable Common or
shares of New Common Stock, respectively, therein as provided in this subsection
2.6. Any party desiring to so participate shall give written notice (a
"PIGGYBACKING NOTICE") to the Securities Holder requesting such Demand
Registration and, if such party is not the Company, to the Company no later than
fifteen (15) days following receipt of a Securities Holder Sale Notice, of the
aggregate number of shares of Registerable Common that such Piggybacking
Securities Holder or shares of New Common Stock that the Company, as the case
may be, then desires to offer and sell in such Securities Holder Public Sale
Event.

                  (b) The extent to which a Piggybacking Securities Holder or
the Company may participate in any Securities Holder Public Sale Event in
accordance with paragraph (a) of this subsection 2.6 shall be limited to that
number of shares of Registerable Common or shares of New Common Stock that will
not require a reduction in the number of shares of Registerable Common of the
Initiating Securities Holders or the Securities Holder requesting such Demand
Registration to be included therein or change in a manner materially adverse to
such Initiating Securities Holders or Securities Holder, as the case may be, the
proposed method of the offering, including, without limitation, the economic
benefits to such Initiating Securities Holders or Securities Holder. If the lead
managing underwriter selected by the Initiating Securities Holders or the
Securities Holder initiating such Securities Holder Public Sale Event (or, if
the offering is not underwritten, a financial advisor to such Initiating
Securities Holders or Securities Holder) determines that marketing factors
require a limitation on the number of shares of Registerable Common or shares of
New Common Stock to be offered and sold in such offering, there shall be
included in the Registration Statement with respect to such offering only that
number of shares of Registerable Common held by such Securities Holders or
shares of New Common Stock to be sold by the Company, if any, that such lead
managing underwriter or financial advisor, as the case may be, reasonably and in
good faith believes will not jeopardize the success of the offering, which
shares shall be allocated FIRST among the Piggybacking Securities Holders on a
PRO RATA basis based on the number of shares of Registerable Common each such
Securities Holder is seeking to include in such offering and SECOND to the
Company.

                  Section 3.  COMPANY PUBLIC SALE EVENTS.

                  3.1. DETERMINATION. Subject to subsection 6.1, the Company may
at any time effect a Company Public Sale Event pursuant to a Registration
Statement filed by the Company,

                                      -8-

<PAGE>

PROVIDED that the Company gives each Securities Holder a Company Sale Notice, no
less than 21 days prior to the filing of the related Registration Statement.

                  3.2. NOTICE. The Company Sale Notice shall contain a statement
that the Securities Holders are entitled to participate in such offering and the
number of shares of Registerable Common which represents the best estimate of
the lead managing underwriter (or, if not known or applicable, the Company) that
will be available for sale by the Securities Holders in the proposed offering.

                  3.3. PIGGYBACK RIGHTS OF SECURITIES HOLDERS. (a) If the
Company shall have delivered a Company Sale Notice, Securities Holders shall be
entitled to participate on the same terms and conditions as the Company in the
Company Public Sale Event to which such Company Sale Notice relates and to offer
and sell shares of Registerable Common therein only to the extent provided in
this subsection 3.3. Each Securities Holder desiring to participate in such
offering shall notify the Company in writing, by delivering a Piggybacking
Notice no later than ten (10) days following receipt of a Company Sale Notice in
respect of a Company Public Sale Event of the aggregate number of shares of
Registerable Common that such Securities Holder then desires to sell in the
offering.

                  (b) Each Securities Holder desiring to participate in a
Company Public Sale Event may include shares of Registerable Common in any
Registration Statement relating to a Company Public Sale Event to the extent
that the inclusion of such shares shall not reduce the number of shares of New
Common Stock to be offered and sold by the Company to be included therein or
change in a manner materially adverse to the Company the proposed method of the
offering, including, without limitation, the economic benefits to the Company.
If the lead managing underwriter selected by the Company for such offering (or,
if the offering is not underwritten, a financial advisor to the Company)
determines that marketing factors require a limitation on the number of shares
of Registerable Common to be offered and sold in such Company Public Sale Event,
there shall be included in the offering only that number of shares of
Registerable Common, if any, that such lead managing underwriter or financial
advisor, as the case may be, reasonably and in good faith believes will not
jeopardize the success of the offering, which shares of Registerable Common
shall be allocated among such Securities Holders on a PRO RATA basis based on
the number of shares of Registerable Common each such Securities Holder is
seeking to include in such Sale Event.

                  3.4. DISCRETION OF THE COMPANY. . In connection with any
Company Public Sale Event, subject to the provisions of this Agreement, the
Company, in its sole discretion, shall determine whether (a) to proceed with,
withdraw from or terminate such Company Public Sale Event, (b) to enter into the
Purchase Agreement for such Company Public Sale Event, and (c) to take such
actions as may be necessary to close the sale of New Common Stock contemplated
by such offering, including, without limitation, waiving any conditions to
closing such sale which have not been fulfilled.

                  Section 4.  BLACK-OUT PERIODS.

                  4.1. BLACK-OUT PERIODS FOR SECURITIES HOLDERS. (a) No
Securities Holder shall offer to sell or sell any shares of Registerable Common
pursuant to a Demand Registration, and

                                      -9-

<PAGE>

the Company shall not be required to supplement or amend any Registration
Statement or otherwise facilitate the sale of Registerable Common pursuant
thereto, during the 90-day period (or such lesser number of days until the
Company makes its next required filing under the Exchange Act) immediately
following the receipt by each Securities Holder of a certificate of an
authorized officer of the Company to the effect that the Board of Directors of
the Company has in good faith and for valid business reasons requested that the
Securities Holders refrain from selling shares of Registerable Common; PROVIDED,
HOWEVER, that the identity of a potential purchaser or purchasers of
Registerable Common from a Securities Holder shall not constitute a valid
business reason. Any period described in this subsection 4.1(a) during which
Securities Holders are not able to sell shares of Registerable Common pursuant
to a Demand Registration is herein referred to as a "black-out" period. The
Company shall notify each Securities Holder of the expiration or earlier
termination of any "black-out" period (the nature and pendency of which need not
be disclosed during such "black-out" period).

                  (b) The period during which the Company is required pursuant
to subsection 2.2 to keep any Demand Registration effective shall be extended by
a number of days equal to the number of days, if any, of any "black-out" period
applicable to Securities Holders pursuant to this subsection 4.1 occurring
during such period, plus a number of days equal to the number of days during
such period, if any, of any period during which the Securities Holders are
unable to sell any shares of Registerable Common pursuant to a Demand
Registration as a result of the happening of any event of the nature described
in subsection 5.3(c)(ii), 5.3(c)(iii) or 5.3(c)(v).

                  Section 5.  AGREEMENTS CONCERNING OFFERINGS.

                  5.1. OBLIGATIONS OF SECURITIES HOLDERS. (a) Each Securities
Holder shall, upon the reasonable request of the Company, advise the Company of
the number of shares of Registerable Common then held or beneficially owned by
it.

                  (b) It shall be a condition precedent to the obligations of
the Company to effect a Registration of any shares of Registerable Common that
the Securities Holders desiring to participate in a Public Sale Event shall have
furnished to the Company a completed Securities Holder's Questionnaire and such
additional information regarding themselves, the Registerable Common held by
them and the intended method of disposition of such securities as shall be
required by law or the Commission to effect the Registration of their
Registerable Common and any other information relating to such Registration
reasonably requested by the Company.

                  5.2. OBLIGATIONS OF THE COMPANY. Whenever required under this
Agreement to proceed with a Registration of any Registerable Common, the Company
shall, subject to the terms and conditions of this Agreement, as expeditiously
as reasonably possible:

                  (a) In accordance with subsection 2.2, prepare and file with
         the Commission a Registration Statement with respect to such
         Registerable Common and use its best efforts to cause such Registration
         Statement to become effective.

                  (b) Prepare and file with the Commission such amendments
         (including post-effective amendments) to such Registration Statement
         and supplements to the related Prospectus used in connection with such
         Registration Statement, and otherwise use its

                                      -10-

<PAGE>

         best efforts, to the end that such Registration Statement reflects the
         plan of distribution of the securities registered thereunder that is
         included in the relevant Notice of offering, if any, in respect of a
         Demand Registration and, subject to subsection 2.2, is effective until
         the completion of the distribution contemplated by such Registration
         Statement or so long thereafter as a dealer is required by law to
         deliver a Prospectus in connection with the offer and sale of the
         shares of Registerable Common covered by such Registration Statement.

                  (c) Notify the Securities Holders selling Registerable Common,
         at any time when a Prospectus relating thereto is required to be
         delivered under the Securities Act, when the Company becomes aware of
         the occurrence of any event, as a result of which the Prospectus
         included in such Registration Statement (as then in effect) contains an
         untrue statement of material fact or omits to state a material fact
         necessary to make the statements therein, in light of the circumstances
         under which they were made, not misleading, and use its best efforts to
         prepare and file promptly, and in any event within 20 days, with the
         Commission a supplement or amendment to such Prospectus so that, as
         thereafter delivered to purchasers of such Registerable Common, such
         Prospectus will not contain an untrue statement of a material fact or
         omit to state a material fact necessary to make the statements therein,
         in light of the circumstances under which they were made, not
         misleading.

                  (d) Provide to any Securities Holder requesting to include
         Registerable Common in such Registration Statement and any managing
         underwriter participating in any distribution thereof, and to any
         attorney, accountant or other agent retained by such Securities Holder
         or managing underwriter, reasonable access to appropriate officers and
         directors of the Company to ask questions and to obtain information
         reasonably requested by any such Person in connection with such
         Registration Statement or any amendment thereto, PROVIDED, HOWEVER,
         that (i) in connection with any such access or request, any such
         requesting Persons shall cooperate to the extent reasonably practicable
         to minimize any disruption to the operation by the Company of its
         business and (ii) any records, information or documents shall be kept
         confidential by such requesting Persons, unless (x) such records,
         information or documents are in the public domain or otherwise publicly
         available other than through disclosure by such requesting party or (y)
         disclosure of such records, information or documents is required by
         court or administrative order or by applicable law (including, without
         limitation, the Securities Act).

                  (e) Furnish to the participating Securities Holders, such
         number of copies of a Prospectus, including a Preliminary Prospectus,
         in conformity with the requirements of the Securities Act, and such
         other documents as they may reasonably request in order to facilitate
         the disposition of Registerable Common owned by them.

                  (f) Use its best efforts to register and qualify the
         securities covered by such Registration Statement under such other
         securities or "Blue Sky" laws of such jurisdictions in the United
         States as shall be reasonably requested by the Securities Holders,
         PROVIDED that the Company shall not be required in connection therewith
         or as a condition thereto to qualify to do business or to file a
         general consent to service of

                                      -11-

<PAGE>

         process in any such states or jurisdictions or to make any filing or
         take any other action which could subject it to taxation as a result
         of such filing.

                  (g) Enter into and perform its obligations under a Purchase
         Agreement, if the offering is an underwritten offering, in usual and
         customary form, with the managing underwriter of such underwritten
         offering; PROVIDED, HOWEVER, that each Securities Holder participating
         in such Public Sale Event shall also enter into and perform its
         obligations under such Purchase Agreement so long as such obligations
         are usual and customary obligations of selling stockholders in a
         registered public offering.

                  5.3. AGREEMENTS RELATED TO OFFERINGS. Subject to the terms and
conditions hereof, in connection with any Demand Registration:

                  (a) The Company will cooperate with any underwriters for, and
         the Securities Holders of, the shares of Registerable Common proposed
         to be sold pursuant to a Registration Statement, and will, unless the
         parties to the Purchase Agreement otherwise agree, enter into a
         Purchase Agreement not inconsistent with the terms and conditions of
         this Agreement and containing such other terms and conditions of a type
         and form reasonable and customary for companies of similar size and
         credit rating (including, but not limited to, such provisions for
         delivery of a "comfort letter" and legal opinion as are customary), and
         take all such other reasonable actions as are necessary or advisable to
         permit, expedite and facilitate the disposition of such shares of
         Registerable Common in the manner contemplated by such Registration
         Statement in each case to the same extent as if all the shares of
         Registerable Common then being offered were for the account of the
         Company.

                  (b) Neither a Registration Statement nor any amendment or
         supplement thereto will be filed by the Company until counsel for the
         Initiating Securities Holder or the securities Holder delivering the
         relevant effective Securities Holder Sale Notice shall have had a
         reasonable opportunity to review the same and each Securities Holder
         participating in such Sale Event shall have had a reasonable
         opportunity to exercise its rights under subsection 5.2(d) with respect
         thereto. No amendment to such Registration Statement naming any
         Securities Holder as a selling security holder shall be filed with the
         Commission until such Securities Holder shall have had a reasonable
         opportunity to review such Registration Statement as originally filed.
         Neither such Registration Statement nor any related Prospectus or any
         amendment or supplement thereto shall be filed by the Company with the
         Commission which shall be disapproved (for reasonable cause) by the
         managing underwriters named therein or any participating Securities
         Holders within a reasonable period after notice thereof.

                  (c) The Company will use its reasonable efforts to keep the
         Securities Holders informed of the Company's best estimate of the
         earliest date on which such Registration Statement or any
         post-effective amendment thereto will become effective and will notify
         each Securities Holder and the managing underwriters participating in
         the distribution pursuant to such Registration Statement promptly (i)
         when such Registration Statement or any post-effective amendment to
         such Registration Statement becomes effective, (ii) of any request by
         the Commission for an amendment or any supplement to such Registration

                                      -12-

<PAGE>

         Statement or any related Prospectus, (iii) of the issuance by the
         Commission of any stop order suspending the effectiveness of such
         Registration Statement or of any order preventing or suspending the use
         of any related Prospectus or the initiation or threat of any proceeding
         for that purpose, (iv) of the suspension of the qualification of any
         shares of New Common Stock included in such Registration Statement for
         sale in any jurisdiction or the initiation or threat of a proceeding
         for that purpose, (v) of any determination by the Company that an event
         has occurred (the nature and pendency of which need not be disclosed
         during a "black-out period" pursuant to subsection 4.1) which makes
         untrue any statement of a material fact made in such Registration
         Statement or any related Prospectus or which requires the making of a
         change in such Registration Statement or any related Prospectus in
         order that the same will not contain any untrue statement of a material
         fact or omit to state a material fact required to be stated therein or
         necessary to make the statements therein not misleading and (vi) of the
         completion of the distribution contemplated by such Registration
         Statement if it relates to a Company Sale Event.

                  (d) In the event of the issuance of any stop order suspending
         the effectiveness of such Registration Statement or of any order
         suspending or preventing the use of any related Prospectus or
         suspending the qualification of any shares of Common Stock included in
         such Registration Statement for sale in any jurisdiction, the Company
         will use its reasonable best efforts promptly to obtain its withdrawal.

                  (e) The Company agrees to otherwise use its best efforts to
         comply with all applicable rules and regulations of the Commission, and
         make available to its security holders, as soon as reasonably
         practicable, but not later than fifteen months after the effective date
         of such Registration Statement, an earnings statement covering the
         period of at least twelve months beginning with the first full fiscal
         quarter after the effective date of such Registration Statement, which
         earnings statement shall satisfy the provisions of Section 11(a) of the
         Securities Act and Rule 158 promulgated thereunder.

                  (f) The Company shall, subject to permitted "black-out"
         periods, upon the happening of any event of the nature described in
         subsection 5.3(c)(ii), 5.3(c)(iii) or 5.3(c)(v), as expeditiously as
         reasonably possible, prepare a supplement or post-effective amendment
         to the applicable Registration Statement or a supplement to the related
         Prospectus or any document incorporated therein by reference or file
         any other required documents and deliver a copy thereof to each
         Securities Holder so that, as thereafter delivered to the purchasers of
         the Registerable Common being sold thereunder, such Prospectus will not
         contain an untrue statement of a material fact or omit to state a
         material fact required to be stated therein or necessary to make the
         statements therein, in light of the circumstances under which they were
         made, not misleading.

                  (g) ) Upon receipt of any notice from the Company of the
         happening of any event of the kind described in subsection 5.2(c), each
         Securities Holder will immediately discontinue disposition of the
         Registerable Common pursuant to the Registration Statement relating to
         such Registerable Common until such Securities Holder's receipt of the
         copies of the supplemented or amended Prospectus contemplated by
         subsection 5.2(c), or until such Securities Holder has been advised in
         writing by the Company that

                                      -13-

<PAGE>

         the use of the Prospectus may be resumed and has received copies of
         any additional or supplemental filings which are incorporated by
         reference therein. If reasonably requested by the Company, the
         Securities Holders will, or will request the managing underwriter or
         underwriters, if any, to, deliver to the Company all copies, other
         than permanent file copies, of the Prospectus covering the
         Registerable Common current at the time of receipt of such notice.

                  5.4. CERTAIN EXPENSES. The Company shall pay all fees,
disbursements and expenses in connection with the performance of its obligations
hereunder, including, without limitation, all registration and filing fees,
printing expenses, auditors' fees, listing fees, registrar and transfer agents'
fees, reasonable fees and disbursements of one counsel (and appropriate local
counsel) to the Securities Holders in connection with each Sale Event (which
counsel shall be selected by EQSF, if any Affiliate of EQSF is participating in
such Sale Event, and if no such Affiliate is participating, by the Securities
Holders holding a majority of the Registrable Securities that are the subject of
such Sale Event) and counsel for the Company, expenses (including reasonable
fees and disbursements of counsel) of complying with applicable securities or
"Blue Sky" laws and the fees of the NASD or other governing body of any
securities exchange on which the New Common Stock is listed in connection with
its review of any offering contemplated in such Registration Statement, but not
including underwriting fees, discounts and commissions.

                  5.5.  REPORTS UNDER THE EXCHANGE ACT; RULE 144.  (a)  The
Company agrees to:

                  (i) file with the Commission in a timely manner all reports
         and other documents required of the Company under the Securities Act or
         the Exchange Act; and

                  (ii) furnish to any Securities Holder forthwith upon request
         (A) a written statement by the Company that it has complied with the
         current public information and reporting requirements of Rule 144 or
         any similar rule or regulation hereafter adopted by the Commission and
         the Exchange Act, (B) a copy of the most recent annual or quarterly
         report of the Company and such other reports and documents so filed by
         the Company, and (C) such other information as is available to the
         Company without unreasonable cost or expense and may be reasonably
         requested in connection with availing any Securities Holder of any rule
         or regulation of the Commission which permits the selling of any such
         securities without Registration or pursuant to such rule or regulation.

                  (b) During any period in which the Company is not subject to
Section 13 or 15(d) of the Exchange Act, the Company shall, upon the request of
any Securities Holder, make available to such Securities Holder and any
prospective purchaser of Registerable Common designated by such Securities
Holder the information required by Rule 144(c) in order to permit resales of the
Registerable Common held by such Securities Holder pursuant to Rule 144.

                  (c) Any Securities Holder selling shares of Registerable
Common pursuant to Rule 144 shall promptly deliver to the Company a copy of the
completed Form 144 filed by such Securities Holder with the Commission.

                                      -14-

<PAGE>

                  5.6. LIMITATIONS ON SUBSEQUENT REGISTRATION RIGHTS. From and
after the date of this Agreement, the Company shall not, without the prior
written consent of Securities Holders owning a majority of the Registerable
Common held by Securities Holders at such time, enter into any agreement (other
than this Agreement) which would allow any holder or prospective holder of New
Common Stock (a) on demand of such holder to cause the Company to effect a
Registration of such securities prior to the thirty (30) month anniversary of
the Effective Date, (b) to include such securities in any Registration Statement
filed under subsection 2.2 hereof to the exclusion of shares of Registerable
Common that any Securities Holder desires to include in any such offering or (c)
to include such securities in any Company Public Sale Event to the exclusion of
shares of Registerable Common that any Securities Holder desires to include in
any such offering.

                  5.7. INDEMNIFICATION AND CONTRIBUTION. In connection with a
Demand Registration, provisions substantially in conformity with the following
provisions shall be contained in the related Purchase Agreement unless the
parties to such Purchase Agreement agree otherwise:

                  (i) The Company shall agree to indemnify and hold harmless
         each Securities Holder and each Person, if any, who controls such
         Securities Holder within the meaning of Section 15 of the Securities
         Act or Section 20 of the Exchange Act against any losses, claims,
         damages or liabilities, joint or several, or actions in respect thereof
         to which such Securities Holder or controlling Person may become
         subject under the Securities Act, or otherwise (collectively,
         "LOSSES"), insofar as such Losses arise out of, or are based upon, any
         untrue statement or alleged untrue statement of any material fact
         contained in such Registration Statement, any related Preliminary
         Prospectus or any related Prospectus, or any amendment or supplement
         thereto, or arise out of, or are based upon the omission or alleged
         omission to state therein a material fact required to be stated therein
         or necessary to make the statements therein not misleading, and will
         reimburse such Securities Holder or controlling Person for any legal or
         other expenses reasonably incurred by them in connection with
         investigating or defending any such Loss; PROVIDED, however, that the
         Company shall not be so liable to the extent that any such Loss arises
         out of, or is based upon, an untrue statement or alleged untrue
         statement of a material fact or an omission or alleged omission to
         state a material fact in said Registration Statement, said Preliminary
         Prospectus, said Prospectus or any said amendment or supplement in
         reliance upon, and in conformity with, written information furnished to
         the Company by or on behalf of a Securities Holder specifically for use
         therein. Notwithstanding the foregoing, the Company shall not be liable
         in any such case to the extent that any such Loss arises out of, or is
         based upon, an untrue statement or alleged untrue statement or omission
         or alleged omission made in any Preliminary Prospectus if (A) such
         Securities Holder failed to send or deliver a copy of the Prospectus
         with or prior to the delivery of written confirmation of the sale of
         Registerable Common to the Person asserting such Loss or who purchased
         such Registerable Common which is the subject thereof if, in either
         case, such delivery is required by the Securities Act and (B) the
         Prospectus would have corrected such untrue statement or omission or
         alleged untrue statement or alleged omission; and the Company shall not
         be liable in any such case to the extent that any such Loss arises out
         of, or is based upon, an untrue statement or alleged untrue statement
         of a material fact or omission or alleged omission to state a material
         fact in the Prospectus, if

                                      -15-

<PAGE>

         such untrue statement or alleged untrue statement, omission or alleged
         omission is corrected in an amendment or supplement to the Prospectus
         and if, having previously been furnished by or on behalf of the
         Company with copies of the Prospectus as so amended or supplemented,
         such Securities Holder thereafter fails to deliver such Prospectus as
         so amended or supplemented, prior to or concurrently with the sale of
         Registerable Common to the Person asserting such Loss or who purchased
         such Registerable Common which is the subject thereof if, in either
         case, such delivery is required by the Securities Act. This indemnity
         agreement will be in addition to any liability which the Company may
         otherwise have.

                  (ii) Each Securities Holder severally shall agree to indemnify
         and hold harmless the Company, each of its officers and directors who
         sign the Registration Statement, each other Securities Holder and each
         Person, if any, who controls the Company or such other Securities
         Holder within the meaning of Section 15 of the Securities Act or
         Section 20 of the Exchange Act against any Losses to which the Company,
         such officers or directors, such other Securities Holder or such
         controlling Person may become subject under the Securities Act, or
         otherwise, insofar as such Losses arise out of, or are based upon, any
         untrue statement or alleged untrue statement of any material fact
         contained in such Registration Statement, any related Preliminary
         Prospectus or any related Prospectus, or any amendment or supplement
         thereto, or arise out of, or are based upon the omission or alleged
         omission to state therein a material fact required to be stated therein
         or necessary to make the statements therein not misleading, and will
         reimburse the Company, such officers or directors, such other
         Securities Holder or such controlling Person for any legal or other
         expenses reasonably incurred by them in connection with investigating
         or defending any such Loss, in each case to the extent, but only to the
         extent, that any such Loss arises out of, or is based upon, an untrue
         statement or alleged untrue statement of a material fact or an omission
         or alleged omission to state a material fact in said Registration
         Statement, said Preliminary Prospectus or said Prospectus, or any said
         amendment or supplement in reliance upon, and in conformity with,
         written information furnished to the Company by or on behalf of such
         Securities Holder specifically for use therein; PROVIDED, HOWEVER, that
         the liability of each Securities Holder on account of the foregoing
         shall be limited to an amount equal to the net proceeds of the sale of
         shares of Registerable Common by such Securities Holder in the offering
         which gave rise to the liability.

                  (iii) The Company shall agree to indemnify and hold harmless
         each underwriter and each Person, if any, who controls any such
         underwriter within the meaning of Section 15 of the Securities Act or
         Section 20 of the Exchange Act against any Losses to which such
         underwriter or controlling Person may become subject under tile
         Securities Act, or otherwise, insofar as such Losses arise out of, or
         are based upon, any untrue statement or alleged untrue statement of any
         material fact contained in such Registration Statement, any related
         Preliminary Prospectus or any related Prospectus, or any amendment or
         supplement thereto, or arise out of, or are based upon the omission or
         alleged omission to state therein a material fact required to be stated
         therein or necessary to make the statements therein not misleading, and
         will reimburse such underwriter or controlling Person for any legal or
         other expenses reasonably incurred by them in connection with
         investigating or defending any such Loss; PROVIDED, HOWEVER, that the

                                      -16-

<PAGE>

         Company shall not be so liable to the extent that any such Loss arises
         out of, or is based upon, an untrue statement or alleged untrue
         statement of a material fact or an omission or alleged omission to
         state a material fact in said Registration Statement, said Preliminary
         Prospectus or said Prospectus or any said amendment or supplement in
         reliance upon, and in conformity with, written information furnished to
         the Company by or on behalf of such underwriter specifically for use
         therein. Notwithstanding the foregoing, the Company shall not be liable
         in any such case to the extent that any such Loss arises out of, or is
         based upon, an untrue statement or alleged untrue statement or omission
         or alleged omission made in any Preliminary Prospectus if (A) such
         underwriter failed to send or deliver a copy of the Prospectus with or
         prior to the delivery of written confirmation of the sale of
         Registerable Common to the Person asserting such Loss or who purchased
         such Registerable Common which is the subject thereof if, in either
         case, such delivery is required by the Securities Act and (B) the
         Prospectus would have corrected such untrue statement or omission or
         alleged untrue statement or alleged omission; and the Company shall not
         be liable in any such case to the extent that any such Loss arises out
         of, or is based upon, an untrue statement or alleged untrue statement
         of a material fact or omission or alleged omission to state a material
         fact in the Prospectus, if such untrue statement or alleged untrue
         statement, omission or alleged omission is corrected in an amendment or
         supplement to the Prospectus and if, having previously been furnished
         by or on behalf of the Company with copies of the Prospectus as so
         amended or supplemented, such underwriter thereafter fails to deliver
         such Prospectus as so amended or supplemented, prior to or concurrently
         with the sale of Registerable Common to the Person asserting such Loss
         or who purchased such Registerable Common which is the subject thereof
         if, in either case, such delivery is required by the Securities Act.
         This indemnity agreement will be in addition to any liability which the
         Company may otherwise have, PROVIDED that the Company shall only be
         required to provide the indemnification described in this subsection
         5.7(a)(iii) to an underwriter and each Person, if any, who controls
         such underwriter if such underwriter agrees to indemnification
         provisions substantially in the form set forth in subsection 5.7(b).

                  (iv) Each Securities Holder severally shall agree to indemnify
         and hold harmless each underwriter and each Person, if any, who
         controls such underwriter within the meaning of Section 15 of the
         Securities Act or Section 20 of the Exchange Act against any Losses,
         joint or several, or actions in respect thereof to which such
         underwriter or such controlling Person may become subject under the
         Securities Act, or otherwise, insofar as such Losses arise out of, or
         are based upon, any untrue statement or alleged untrue statement of any
         material fact contained in such Registration Statement, any related
         Preliminary Prospectus or any related Prospectus, or any amendment or
         supplement thereto, or arise out of, or are based upon the omission or
         alleged omission to state therein a material fact required to be stated
         therein or necessary to make the statements therein not misleading, and
         will reimburse such underwriter or such controlling Person for any
         legal or other expenses reasonably incurred by them in connection with
         investigating or defending any such Loss, in each case to the extent,
         but only to the extent, that any such Loss arises out of, or is based
         upon, an untrue statement or alleged untrue statement of a material
         fact or an omission or alleged omission to state a material fact in
         said Registration Statement, said Preliminary Prospectus or said
         Prospectus, or any said amendment or supplement in reliance upon, and
         in conformity

                                      -17-

<PAGE>

         with, written information furnished to the Company by or on behalf of
         such Securities Holder specifically for use therein; PROVIDED that the
         liability of such Securities Holder on account of the foregoing shall
         be limited to an amount equal to the net proceeds of the sale of
         shares of Registerable Common by such Securities Holder in the
         offering which gave rise to the liability. Notwithstanding the
         foregoing, such Securities Holder shall not be liable in any such case
         to the extent that any such Loss arises out of, or is based upon, an
         untrue statement or alleged untrue statement or omission or alleged
         omission made in any Preliminary Prospectus if (A) such underwriter
         failed to send or deliver a copy of the Prospectus with or prior to
         the delivery of written confirmation of the sale of Registerable
         Common to the Person asserting such Loss or who purchased such
         Registerable Common which is the subject thereof if, in either case,
         such delivery is required by the Securities Act and (B) the Prospectus
         would have corrected such untrue statement or omission or alleged
         untrue statement or alleged omission; and such Securities Holder shall
         not be liable in any such case to the extent that any such Loss arises
         out of, or is based upon, an untrue statement or alleged untrue
         statement of a material fact or omission or alleged omission to state
         a material fact in the Prospectus, if such untrue statement or alleged
         untrue statement, omission or alleged omission is corrected in an
         amendment or supplement to the Prospectus and if, having previously
         been furnished with copies of the Prospectus as so amended or
         supplemented, such underwriter thereafter fails to deliver such
         Prospectus as so amended or supplemented, prior to or concurrently
         with the sale of Registerable Common to the Person asserting such Loss
         or who purchased such Registerable Common which is the subject thereof
         if, in either case, such delivery is required by the Securities Act.
         No Securities Holder shall be required to provide the indemnification
         described in this subsection 5.7(a)(iv) to an underwriter or any
         Person who controls such underwriter if such underwriter has not
         agreed to indemnification provisions substantially in the form set
         forth in subsection 5.7(b).

                  (v) Promptly after receipt by an indemnified party pursuant to
         the indemnification provisions of such Purchase Agreement of notice of
         any claim or the commencement of any action, the indemnified party
         shall, if a claim in respect thereof is to be made against the
         indemnifying party pursuant to such indemnification provisions, notify
         the indemnifying party in writing of the claim or the commencement of
         that action; PROVIDED, HOWEVER, that the failure to notify the
         indemnifying party shall not relieve it from any liability which it may
         have to the indemnified party otherwise than pursuant to the
         indemnification provisions of such Purchase Agreement unless the
         indemnifying party is materially prejudiced by such lack of notice. If
         any such claim or action shall be brought against an indemnified party,
         and it shall notify the indemnifying party thereof, the indemnifying
         party shall be entitled to participate in defense of such claim, and,
         to the extent that it wishes, jointly with any other similarly notified
         indemnifying party, to assume the defense thereof with counsel
         reasonably satisfactory to the indemnified party. After notice from the
         indemnifying party to the indemnified party of its election to assume
         the defense of such claim or action, (x) the indemnifying party shall
         not be liable to the indemnified party pursuant to the indemnification
         provisions hereof or of such Purchase Agreement for any legal or other
         expenses subsequently incurred by the indemnified party in connection
         with the defense thereof other than reasonable costs of investigation,
         (y) the indemnifying party shall not be liable for the costs and
         expenses of or Losses arising out of any settlement of such claim or
         action unless such settlement was

                                      -18-

<PAGE>

          effected with the consent of the indemnifying party and (z) the
          indemnified party shall be obligated to cooperate with the
          indemnifying party in the investigation of such claim or action;
          PROVIDED, HOWEVER, that the Securities Holders (together with their
          respective controlling Persons) and the underwriters (together with
          their respective controlling Persons) shall each as a separate group
          have the right to employ one separate counsel to represent such
          Securities Holders and such underwriters (and their respective
          controlling Persons) who may be subject to liability arising out of
          any claim in respect of which indemnity may be sought by such
          Securities Holders and underwriters against the Company pursuant to
          the indemnification provisions of such Purchase Agreement if, in the
          reasonable judgment of either Securities Holders' counsel or counsel
          for the underwriters, there exists an actual or potential conflict of
          interest between such Securities Holders (and its controlling persons)
          on the one hand and such underwriters (and their controlling persons)
          on the other, and in that event the reasonable fees and expenses of
          both such separate counsel shall also be paid by the Company.

                  (a) As a condition to agreeing in any Purchase Agreement to
the indemnification provisions described in subsection 5.7(a)(iii) and
5.7(a)(iv) in favor of an underwriter participating in the offering covered by
the related Registration Statement and its controlling Persons, the Company and
the Securities Holders participating in an offering pursuant to such
Registration Statement may require that such underwriter agree in the Purchase
Agreement to provisions substantially in the form set forth in subsection
5.7(a)(v) and to severally indemnify and hold harmless the Company, each of its
officers and directors who sign such Registration Statement, each Securities
Holder participating in such offering and each Person, if any, who controls the
Company or such Securities Holder within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act against any Losses to which the
Company, such officers and directors, such Securities Holder or such controlling
Person may become subject under the Securities Act, or otherwise, insofar as
such Losses arise out of, or are based upon, any untrue statement or alleged
untrue statement of any material fact contained in such Registration Statement
in which such underwriter is named as an underwriter, any related Preliminary
Prospectus or any related Prospectus, or any amendment or supplement thereto, or
arise out of, or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, and to reimburse the Company, such officers
and directors, such Securities Holder or such controlling Person for any legal
or other expenses reasonably incurred by them in connection with investigating
or defending any such Loss in each case to the extent, but only to the extent,
that any such Loss arises out of, or is based upon, an untrue statement or
alleged untrue statement of a material fact or an omission or alleged omission
to state a material fact in said Registration Statement, said Preliminary
Prospectus or said Prospectus or any said amendment or supplement in reliance
upon, and in conformity with, written information furnished to the Company by or
on behalf of such underwriter specifically for use therein.

                  (b) In order to provide for just and equitable contribution
between the Company and such Securities Holders in circumstances in which the
indemnification provisions described in this subsection 5.7 and contained in any
Purchase Agreement are for any reason insufficient or inadequate to hold the
indemnified party harmless (other than as a result of their nonapplicability in
accordance with their terms), the Company and such Securities Holders shall
contribute to the aggregate Losses (including any investigation, legal and other
expenses

                                      -19-

<PAGE>

reasonably incurred in connection with, and any amount paid in settlement of,
any action, suit or proceeding or any claims asserted, but after deducting any
contribution actually received from Persons other than the Company and such
Securities Holders) incurred by the Company and one or more of its directors or
its officers who sign such Registration Statement or such Securities Holders or
any controlling Person of any of them, in such proportion as is appropriate to
reflect their relative degrees of fault in connection with the actions which
resulted in such Losses, as well as any other relevant equitable considerations.
The relative fault of the Company and of such Securities Holder shall be
determined by reference to, among other things, whether the untrue or allegedly
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or by such
Securities Holder and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission;
PROVIDED, HOWEVER, that the liability of each such Securities Holder to make
such contribution shall be limited to an amount equal to the net proceeds of the
sale of shares of Registerable Common by such Securities Holder in the offering
which gave rise to the liability. As among themselves, such Securities Holders
agree to contribute to amounts payable by other such Securities Holders in such
manner as shall, to the extent permitted by law, give effect to the provisions
in such Purchase Agreement comparable to subsection 5.7(a)(ii). The Company and
such Securities Holders agree that it would not be just and equitable if their
respective obligations to contribute pursuant to this subsection 5.7(c) were to
be determined by PRO RATA allocation (other than as set forth above) of the
aggregate Losses by reference to the proceeds realized by such Securities
Holders in a sale pursuant to said Registration Statement or said Prospectus or
by any other method of allocation which does not take account of the
considerations set forth in this subsection 5.7(c). No Person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution under this subsection from any
Person who was not guilty of such fraudulent misrepresentation.

                  (c) The Company and the Securities Holders participating in an
offering pursuant to a Registration Statement agree that, if the underwriters
participating in a Public Sale Event are agreeable, the Purchase Agreement, if
any, relating to such Registration Statement shall contain provisions to the
effect that in order to provide for just and equitable contribution between such
underwriters on the one hand and the Company and such Securities Holders on the
other hand in circumstances in which the indemnification provisions of such
Purchase Agreement are for any reason insufficient or inadequate to hold the
indemnified party harmless (other than as a result of their non-applicability in
accordance with their terms), the Company and such Securities Holders on the one
hand and such underwriters on the other hand will contribute on the basis herein
set forth to the aggregate Losses (including any investigation, legal and other
expenses incurred in connection with, and any amount paid in settlement of, any
action, suit or proceeding or claims asserted, but after deducting any
contribution actually received from Persons other than the Company and such
Securities Holders and such underwriters), incurred by the Company and one or
more of its directors or its officers who sign such Registration Statement or
such Securities Holders or such underwriters, or any controlling Person of any
of them, in such proportion as is appropriate to reflect their relative degrees
of fault in connection with the actions which resulted in such Losses, as well
as any other relevant equitable considerations. The relative fault of the
Company, of such Securities Holders and of such underwriter shall be determined
by reference to, among other things, whether the untrue or allegedly untrue
statement of a material fact or the omission or alleged omission to state a

                                      -20-

<PAGE>

material fact relates to information supplied by the Company, by such Securities
Holders or by such underwriter and the parties, relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission. Notwithstanding the provisions set forth above, (x) no underwriter
shall be required to contribute any amount in excess of the amount by which the
total price at which the shares of New Common Stock underwritten by it and
distributed to the public were offered to the public exceeds the amount of any
damages which such underwriter has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission and (y)
the liability of each such Securities Holder to make such contribution shall be
limited to an amount equal to the net proceeds of the sale of shares of
Registerable Common by such Securities Holder in the offering which gave rise to
the liability. As among themselves, such Securities Holders agree to contribute
to amounts payable by other such Securities Holders in such manner as shall, to
the extent permitted by law, give effect to the provisions in such Purchase
Agreement comparable to subsection 5.7(a)(ii). As between the Company and such
Securities Holders, such parties agree that it would not be just and equitable
if their respective obligations to contribute pursuant to this subsection 5.7(d)
were to be determined by PRO RATA allocation (other than as set forth above) of
the aggregate Losses by reference to the proceeds realized by such Securities
Holders in a sale pursuant to said Registration Statement or said Prospectus or
by any other method of allocation which does not take account of the
considerations set forth in this subsection 5.7(d). No Person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution under the provisions set forth
above from any Person who was not guilty of such fraudulent misrepresentation.

                  (d) The obligations of the Company and the Securities Holders
participating in any distribution of shares of Registerable Common under the
provisions of this subsection 5.7 and provisions in any Purchase Agreement
substantially similar to subsections 5.7(a), 5.7(b), 5.7(c) or 5.7(d) shall
survive the termination of any or all of the other provisions of this Agreement
or such Purchase Agreement.

                  5.8. UNDERWRITTEN OFFERINGS. If at any time any of the
Securities Holders participating in a Demand Registration desire to sell
Registerable Common in an underwritten offering, the investment banker or
investment bankers that will manage the offering will be selected by (a) if such
Demand Registration was initiated by Initiating Securities Holders, the
Initiating Securities Holders owning a majority of the aggregate number of
shares of Registerable Common that all such Initiating Securities Holders are
seeking to include in the related Sale Event and (b) if such Demand Registration
was initiated by an individual Securities Holder, the Securities Holder
requesting such Securities Holder Public Sale Event, PROVIDED that such
investment banker or bankers must be reasonably satisfactory to the Company.

                  5.9. TRANSFER OF RIGHTS UNDER THIS AGREEMENT; TRANSFERS OF
REGISTERABLE COMMON. (a) At any time, the rights and obligations of a Securities
Holder under this Agreement may be transferred by a Securities Holder to a
transferee of not less than 20% of such Security Holder's Registerable Common,
PROVIDED that, within a reasonable period of time (but in no event later than 10
days) after such transfer, (i) the transferring Securities Holder shall have
furnished the Company and the other Securities Holders written notice of the
name and address of such transferee and the Registerable Common with respect to
which such rights are being transferred and (ii) such transferee shall furnish
the Company and the Securities Holders (other

                                      -21-

<PAGE>

than the transferring Securities Holder) a copy of a duly executed Supplemental
Addendum by which such transferee (A) assumes all of the obligations and
liabilities of its transferor hereunder, (B) enjoys all of the rights of its
transferor hereunder and (C) agrees to be bound hereby.

                  (b) Except with respect to transfers pursuant to paragraph (a)
above, a transferee of Registerable Common shall neither assume any liabilities
or obligations nor enjoy any rights hereunder and shall not be bound by any of
the terms hereof.

                  5.10. TERMINATION OF RIGHTS. The rights granted under this
Agreement shall terminate as to each Securities Holder at such time as such
Securities Holder shall receive, either before or after the Company's receipt of
a Securities Holder Sale Notice or a Piggybacking Notice, an opinion of counsel
to the Company in form reasonably satisfactory to counsel to such Securities
Holder that all of the Registerable Common then held by such Securities Holder
can be sold within a given three (3) month period commencing on the date of such
opinion in a transaction or transactions exempt from the Registration
requirements of the Securities Act.

                  Section 6.  SEQUENCING OF PUBLIC SALE EVENTS.

                  6.1. EFFECTIVE NOTICE PERIOD. (a) Subject to subsections
6.1(b) and 6.1(c), during the term of this Agreement, no priority of right shall
exist between or among Securities Holders or between any Securities Holder, on
the one hand, and the Company, on the other, with respect to providing a Notice
of Offering with respect to, and effecting, a Public Sale Event. Once properly
given, a Securities Holder Sale Notice or a Company Sale Notice regarding a
Company Public Sale Event, as the case may be, shall be effective (and shall
preclude any such Notice of Offering by another party except in accordance with
clause (ii) of Section 2.3(b)) during the period (the "EFFECTIVE NOTICE PERIOD")
commencing on the date of such Notice of Offering and ending on the earliest of
(a) withdrawal of such Notice of Offering (notice of which shall be promptly
effected in the same manner as such Notice of Offering), (b) the abandonment of
the Public Sale Event to which such Notice of Offering relates (notice of which
shall be promptly effected in the same manner as such Notice of Offering) and
(c) the later of (i) 150 days after such a Notice of Offering has been given,
PROVIDED that the Registration Statement relating to such Notice of Offering has
been declared effective within 90 days of such Notice of Offering, and (ii) 90
days after the closing date of the Public Sale Event to which such Notice of
Offering relates.

                  (b) Upon the termination of an Effective Notice Period, any
Securities Holder so entitled pursuant to subsection 2.1 or the Company can
provide a Notice of Offering, PROVIDED that if such Notice of Offering is given
within 12 months after the end of an Effective Notice Period by the party that
gave the immediately preceding Notice of Offering, any other party shall, for
the 45-day period following its receipt of such Notice of Offering, have the
right to preempt such Notice of Offering by itself delivering a Notice of
Offering.

                  (c) Notwithstanding subsection 6.1(a), the Company will have
the right to preempt any Demand Registration by delivering a Company Sale Notice
(within five Business Days after the Company has received the required
Securities Holder Sales Notice) to the Securities Holders indicating that the
Company has identified a specific business need and use for the proceeds of the
related sale and that the Company shall effect such registration as

                                      -22-

<PAGE>

promptly as practicable. In connection with such registration, the Securities
Holders will have such piggyback registration rights as are set forth in Section
3.3 hereof. The Company may exercise the foregoing right to preempt only once in
any 360-day period.

                  6.2. RESTRICTIVE LEGEND ON CERTIFICATES. (a) Each Certificate
evidencing shares of New Common Stock issued in exchange for Notes, subject to
paragraph (b) below, be stamped or otherwise imprinted with a conspicuous legend
in the following form:

                  "The securities evidenced by this certificate may be sold only
                  pursuant to a Registration Statement effective under the
                  Securities Act of 1933, as amended (the "Act"), or an
                  exemption from the provisions of Section 5 Act."

                  (b) A holder of a certificate evidencing shares of New Common
Stock bearing the legend specified in paragraph (a) shall be entitled to receive
from the Company, whether or not in connection with a sale or proposed sale, a
new certificate or certificates evidencing an identical number of shares (the
transfer expenses for which shall be paid by the Company) but without such
legend at such time as (i) such shares are sold pursuant to a Registration
Statement effective under the Securities Act, (ii) such holder furnishes the
Company with a certificate to the effect that such holder is not an affiliate or
an "underwriter" within the meaning of Section 1145(b) of the Bankruptcy Code
and, upon the request of the Company, an opinion of counsel reasonably
satisfactory to the Company to such effect and to the effect that such shares
may be sold without registration under the Securities Act or (iii) the
registration rights granted in this Agreement otherwise terminate in accordance
with subsection 5.10. The shares of the New Common Stock represented by any such
replacement certificate issued without the legend specified in paragraph (a)
pursuant to the immediately preceding sentence shall cease to be Registerable
Common for all purposes of this Agreement.

                  Section 7. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. In
connection with the Registration Statement in respect of any Demand
Registration, the Company shall, on the date of effectiveness of such
Registration Statement with the Commission (the "effective date"), certify to
each Securities Holder in a certificate of a Responsible Officer of the Company
to the effect that the representations and warranties set forth below are true
and correct at and as of the effective date. In connection with any other Sale
Event in which Securities Holders participate, except as otherwise may be agreed
upon by such participating Securities Holders and the Company, the Company shall
represent and warrant in the Purchase Agreement relating to such Sale Event to
the Securities Holders and any underwriters participating in such Sale Event as
follows (except as otherwise indicated, each reference in this Section to "the
Registration Statement" shall refer to a Registration Statement in respect of
any Demand Registration or other such Sale Event in which Securities Holders
participate, including all information deemed to be a part thereof, as amended,
and each reference to "the Prospectus" shall refer to the related Prospectus):

                  (a) (i) When the Registration Statement became (in the case of
         a Demand Registration to be filed pursuant to a Shelf Registration) or
         shall become effective, the Registration Statement did or will comply
         as of its effective date in all material respects with the applicable
         requirements of the Securities Act and the rules and regulations

                                      -23-

<PAGE>

         thereunder; (ii) when the Prospectus is filed in accordance with Rule
         424(b), the Prospectus (and any supplements thereto) will comply in all
         material respects with the applicable requirements of the Securities
         Act and the rules and regulations thereunder; (iii) the Registration
         Statement did not or will not as of its effective date contain any
         untrue statement of a material fact or omit to state any material fact
         required to be stated therein or necessary in order to make the
         statements therein not misleading; and (iv) the Prospectus, if not
         filed pursuant to Rule 424(b), did not or will not as of the date
         thereof, and on the date of any filing pursuant to Rule 424(b), the
         Prospectus (together with any supplement thereto) will not, include any
         untrue statement of a material fact or omit to state a material fact
         necessary in order to make the statements therein, in the light of the
         circumstances under which they were made, not misleading; PROVIDED,
         HOWEVER, that the Company makes no representations or warranties as to
         the information contained in or omitted from the Registration
         Statement, or the Prospectus (or any supplement thereto) in reliance
         upon and in conformity with information furnished in writing to the
         Company by or on behalf of any Securities Holder specifically for use
         in connection with the preparation of the Registration Statement or the
         Prospectus (or any supplement thereto) or any information furnished in
         writing to the Company by or on behalf of any underwriter specifically
         for use in connection with the preparation of the Registration
         Statement or the Prospectus (or any supplement thereto), other than
         that the Company has no knowledge of any such untrue statement or
         omission in respect of such information.

                  (b) The public accountants who certified the Company's
         financial statements in the Registration Statement are independent
         certified public accountants within the meaning of the Securities Act
         and the applicable published rules and regulations thereunder; the
         historical consolidated financial statements, together with the related
         schedules and notes, forming part of the Registration Statement and the
         Prospectus comply in all material respects with the requirements of the
         Securities Act and the rules and regulations thereunder and have been
         prepared, and present fairly in all material respects the consolidated
         financial condition, results of operations and changes in financial
         condition of the Company and its consolidated Subsidiaries at the
         respective dates and for the respective periods indicated, in
         accordance with generally accepted accounting principles applied
         consistently throughout such periods (except as specified therein); and
         the historical consolidated financial data set forth in the Prospectus
         are derived from the accounting records of the Company and its
         consolidated Subsidiaries, and are a fair presentation of the data
         purported to be shown; and the pro forma consolidated financial
         statements (if any), together with the related notes, forming part of
         the Registration Statement and the Prospectus, comply in all material
         respects with the requirements of Regulation S-X under the Securities
         Act.

                  (c) Except as may be set forth in the Prospectus, each member
         of the ICSL Group has been duly incorporated and is validly existing as
         a corporation in good standing under the laws of the jurisdiction in
         which it is chartered or organized, with the corporate power and
         authority to own its properties and conduct its business as described
         in the Prospectus, and is duly qualified to do business as a foreign
         corporation and is in good standing under the laws of each jurisdiction
         which requires such qualification where the failure to be so qualified
         would materially adversely affect the business, operations, property or
         financial condition of the ICSL Group taken as a whole.

                                      -24-

<PAGE>

                  (d) Except as may be set forth in the Prospectus, all the
         outstanding shares of capital stock of each Subsidiary have been duly
         authorized and validly issued and are fully paid and nonassessable by
         the issuer, and all outstanding shares of capital stock of the
         Subsidiaries are owned by the Company either directly or through
         Subsidiaries free and clear of any security interests, claims, liens or
         encumbrances (other than those granted to secure the obligations of the
         ICSL Group in respect of the Company's working capital facility), in
         each case where the failure to so own the capital stock of a Subsidiary
         would materially adversely affect the business, operations, property or
         financial condition of the ICSL Group taken as a whole.

                  (e) Except as may be set forth in the Prospectus, no member of
         the ICSL Group is in violation of any term or provision of any charter,
         by-law, franchise, license, permit, judgment, decree or order or any
         applicable statute, rule or regulation, which violation is material to
         the business, operations, property or financial condition of the ICSL
         Group taken as a whole.

                  (f) Except as may be set forth in the Prospectus, no default
         exists and no event has occurred which with notice, lapse of time, or
         both, would constitute a default, in the due performance and observance
         of any term, covenant or condition of any agreement to which the
         Company or any of the Subsidiaries is a party or by which it or any of
         them is bound, which default would materially adversely affect the
         business, operations, property or financial condition of the ICSL Group
         taken as a whole.

                  (g) Except as may be set forth in the Prospectus, each member
         of the ICSL Group has all requisite corporate power and authority and
         has received and is operating in compliance in all material respects
         with all governmental or regulatory or other franchises, grants,
         authorizations, approvals, licenses, permits, easements, consents,
         certificates and orders, necessary to own its properties and conduct
         businesses as currently owned and conducted and as proposed to be
         conducted, except where the failure to do so would not materially
         adversely affect the business, operations, property or financial
         condition of the ICSL Group, taken as a whole.

                  (h) Except as may be described in the Prospectus, since the
         date of the most recent financial statements included in the
         Prospectus, there has been no material adverse change in the business,
         operations, property or financial condition of the ICSL Group taken as
         a whole, whether or not arising from transactions in the ordinary
         course of business.

                  (i) Except as may be described in the Prospectus, no
         litigation, investigation or proceeding of or before any arbitrator or
         Governmental Authority is pending or, to the best knowledge of the
         Company, threatened against any member of the ICSL Group or against any
         of their respective properties or revenues, existing or future which,
         if adversely determined, could reasonably be expected to have a
         material adverse effect on the business, property or financial
         condition of the ICSL Group taken as a whole, or which otherwise is of
         a character required to be disclosed in the Prospectus; there is no
         franchise, contract or other document of a character required to be
         described in the Registration Statement or the Prospectus, or to be
         filed as an exhibit, which is not

                                      -25-

<PAGE>

         adequately described or filed as required; and such franchises,
         contracts and other documents that are described in the Prospectus
         conform in all material respects to the descriptions thereof contained
         in the Prospectus.

                  (j) Except as may be described in the Prospectus, there is no
         pending or, to the best knowledge of the Company, threatened action,
         suit, or judicial, arbitral, rule-making or other administrative or
         other proceeding against the Company which challenges the validity of
         (i) this Agreement or (ii) any Purchase Agreement entered into in
         connection with the offering or any action taken or to be taken
         pursuant to or in connection with such agreements.

                  (k) The Company's authorized equity capitalization is as set
         forth in the Prospectus; the capital stock of the Company conforms in
         all material respects to the description thereof contained in the
         Prospectus; all of the issued and outstanding shares of capital stock
         of the Company have been duly authorized and validly issued and, except
         as set forth in the Prospectus, are fully paid and nonassessable.

                  (l) The Company has all requisite corporate power and
         authority, has taken all requisite corporate action, and has received
         and is in compliance with all governmental, judicial and other
         authorizations, approvals and orders, necessary in connection with the
         offering, and to carry out the provisions and conditions of this
         Agreement and the Purchase Agreement, if any, related thereto, except
         for such approvals and conditions that need to be obtained or satisfied
         as are set forth in the Prospectus and such approvals or authorizations
         as may be required under the Securities Act, the securities or "Blue
         Sky" laws of any jurisdiction or the rules of any securities exchange
         on which the New Common Stock is listed in connection with the purchase
         and distribution of shares of New Common Stock in the offering. The
         Purchase Agreement, if any, entered into in connection with the
         offering has been duly authorized, executed and delivered by the
         Company and is a valid and binding and enforceable obligation of the
         Company, enforceable against the Company in accordance with its terms,
         except as enforceability may be limited by applicable bankruptcy,
         insolvency, reorganization, moratorium or similar laws affecting the
         enforcement of creditors' rights generally and by general equitable
         principles; PROVIDED, that no representation is made as to the
         validity, binding effect or enforceability of any provision that
         purports to provide indemnification of any Person for any Losses
         resulting from violation by such person of any applicable securities or
         "Blue Sky" laws.

                  (m) To the best knowledge of the Company, neither the sale of
         the New Common Stock to be sold pursuant to the Registration Statement,
         nor the execution, delivery or performance by the Company of the
         Purchase Agreement, if any, entered into in connection with the
         offering or the consummation of any other of the transactions
         contemplated in such Purchase Agreement, if any, will conflict with,
         result in a breach of, or constitute a default under, the charter or
         by-laws of the Company or any of the Subsidiaries or the terms of any
         material indenture or other material agreement or instrument to which
         the Company or any of the Subsidiaries is a party or by which it or any
         of them is bound, or any material statute applicable to the Company or
         any of the

                                      -26-

<PAGE>

         Subsidiaries or any material order, decree, rule or regulation
         applicable to the Company or any of the Subsidiaries of any
         Governmental Authority.

                  (n) Except (i) as set forth in the Prospectus, (ii) for rights
         to registration pursuant to a Registration Statement on Form S-8 and
         (iii) to the extent permitted under subsection 5.6, no holders of
         securities of the Company have rights to the registration of such
         securities under any Registration Statement except the Securities
         Holders.

For purposes of the foregoing representations and warranties, the Company may
assume that any agreement is the valid and binding obligation of any other
parties to such agreement.

                  Section 8. REPRESENTATIONS AND WARRANTIES OF THE SECURITIES
HOLDERS. Each participating Securities Holder shall, in connection with a Sale
Event, if required by the terms of a Purchase Agreement relating to such Sale
Event, for itself severally and not jointly represent and warrant to the
Company, the underwriter or underwriters, if any, and each other Securities
Holder participating in such Sale Event as follows:

                  (a) Such Securities Holder has all requisite power and
         authority to enter into and carry out the terms of this Agreement and
         such Purchase Agreement and the other agreements and instruments
         related to such agreements to which it is a party.

                  (b) Each of this Agreement and such Purchase Agreement has
         been duly authorized, executed and delivered by or on behalf of such
         Securities Holder, and constitutes the valid, binding and enforceable
         obligation of such Securities Holder, except as enforceability may be
         limited by applicable bankruptcy, insolvency, reorganization,
         moratorium or similar laws affecting the enforcement of creditors'
         rights generally and by general equitable principles; PROVIDED, that no
         representation is made as to the validity, binding effect or
         enforceability of any provision purporting to provide indemnification
         of any person for any Losses resulting from violation by such person of
         any applicable securities or "Blue Sky" laws.

                  (c) Such Securities Holder, immediately prior to any sale of
         shares of Registerable Common pursuant to such Purchase Agreement, will
         have good title to such shares of Registerable Common, free and clear
         of all liens, encumbrances, equities or claims (other than those
         created by this Agreement); and, upon payment therefor, good and valid
         title to such shares of Registerable Common will pass to the purchaser
         thereof, free and clear of any lien, charge or encumbrance created or
         caused by such Securities Holder.

                  (d) Such Securities Holder has not taken and will not take,
         directly or indirectly, any action designed to constitute or which has
         constituted or which might reasonably be expected to cause or result
         in, under the Exchange Act or the rules or regulations promulgated
         thereunder or other applicable law, stabilization or manipulation of
         the price of any security of the Company to facilitate the sale or
         resale of shares of Registerable Common.

                  (e) (i) Written information furnished by or on behalf of such
         Securities Holder to the Company expressly for use in the Registration
         Statement, any related Preliminary

                                      -27-

<PAGE>

         Prospectus, or any related Prospectus or any amendment or supplement
         thereto will not contain, in each case as of the date such information
         was furnished, any untrue statement of a material fact or omit to
         state any material fact required to be stated or necessary to make the
         statements in such information not misleading.

                  (f) To the best knowledge of such Securities Holder, neither
         the sale of the Registerable Common to be sold pursuant to the
         Registration Statement, nor the execution, delivery or performance by
         such Securities Holder of the Purchase Agreement, if any, entered into
         in connection with the offering or the consummation of any other of the
         transactions contemplated in such Purchase Agreement, if any, will
         conflict with, result in a breach of, or constitute a default under,
         the charter or by-laws of such Securities Holder or the terms of any
         material indenture or other material agreement or instrument to which
         such Securities Holder is a party or by which it is bound, or any
         material statute applicable to such Securities Holder or any material
         order, decree, rule or regulation applicable to such Securities Holder
         of any Governmental Authority.

                  Section 9. DELIVERY OF COMFORT LETTER AND LEGAL OPINION. On
the date that a Registration Statement relating to a Sale Event in which
Securities Holders participate is declared effective by the Commission, the
Company shall comply with the following:

                  (a) The Company shall have received, and delivered to each
         Securities Holder participating in such Sale Event, a copy of the
         "comfort" letter or letters, or updates thereof according to customary
         practice, of the independent certified public accountants who have
         certified the Company's financial statements included in the
         Registration Statement covering substantially the same matters with
         respect to the Registration Statement (including the Prospectus) and
         with respect to events subsequent to the date of the Company's
         financial statements as are customarily covered in accountants' letters
         delivered to underwriters in underwritten public offerings of
         securities. The Company will use its reasonable best efforts to cause
         such "comfort" letters to be addressed to such Securities Holders.

                  (b) Each Securities Holder and any underwriters participating
         in such offering shall have received an opinion and any updates thereof
         of outside counsel to the Company reasonably satisfactory to such
         Securities Holders and underwriters covering substantially the same
         matters as are customarily covered in opinions of issuer's counsel
         delivered to underwriters in underwritten public offerings of
         securities, addressed to each of such Securities Holders and
         underwriters participating in such offering and dated the closing date
         thereof.

                  Section 10.  MISCELLANEOUS.

                  10.1. NOTICES. All notices, requests and demands to or upon
the respective parties hereto to be effective shall be in writing (including by
facsimile transmission), and, unless otherwise expressly provided herein, shall
be deemed to have been duly given or made when actually delivered or, in the
case of notice by facsimile transmission, when sent and confirmation of receipt
is received. Notices to the Securities Holders shall be deemed to have been
given or

                                      -28-

<PAGE>

made when sent. All notices shall be addressed as follows or to such other
address as may be hereafter designated in writing by the respective parties
hereto:

         The Company:                Innovative Clinical Solutions, Ltd.
                                     10 Dorrance Street, Suite 400
                                     Providence, Rhode Island 02903
                                     Telecopy: 401-553-6466

         The  Securities Holders:    The address of each Securities Holder as
                                     set forth on the signature pages hereof as
                                     the same may be changed by each such
                                     Securities Holder from time to time by
                                     written notice to the Company and the other
                                     Securities Holders.

                  10.2. AMENDMENTS AND WAIVERS. The Securities Holders of not
less than 66-2/3% of the Registerable Common held or beneficially owned by
Securities Holders at any point in time and the Company may from time to time
enter into written amendments, supplements or modifications to this Agreement
for the purpose of adding any provisions hereto or thereto or changing in any
manner the rights of the Securities Holders or the Company hereunder or
thereunder, and the Securities Holders of not less than 66-2/3% of the
Registerable Common held or beneficially owned by Securities Holders at any
point in time may execute a written instrument waiving, on such terms and
conditions as may be specified therein, any of the requirements of this
Agreement which are solely for the benefit of the Securities Holders and where
such waiver does not adversely affect the interests of the Company; PROVIDED,
HOWEVER, that no such waiver and no such amendment, supplement or modification
shall (i) adversely affect the rights of a Securities Holder under Section 2
hereof or (ii) amend, modify or waive any provision of Section 5 or this
subsection 10.2, in each case without the written consent of each Securities
Holder. Any such waiver and any such amendment, modification or supplement shall
apply equally to each of the Securities Holders and the Company.

                  10.3. TERMINATION. This Agreement and the respective
obligations and agreements of the parties hereto, except as otherwise expressly
provided herein, shall terminate on the Termination Date.

                  10.4. SURVIVAL OF REPRESENTATIONS AND WARRANTIES. Except as
they may by their terms relate to an earlier date, all representations and
warranties made hereunder and in any document, certificate or statement
delivered pursuant hereto or in connection herewith shall survive the execution
and delivery of this Agreement and the termination of any or all of the
provisions of this Agreement.

                  10.5. HEADINGS. The descriptive headings of the several
sections and subsections of this Agreement are inserted for convenience only and
shall not control or affect the meaning or construction of any of the provisions
hereof.
                  10.6. COUNTERPARTS. This Agreement may be executed in any
number of counterparts and by the different parties hereto in separate
counterparts, each of which when so executed and delivered shall be an original,
but all of such counterparts shall together constitute one and the same
agreement.

                                      -29-

<PAGE>

                  10.7.  GOVERNING  LAW. THIS  AGREEMENT  SHALL BE GOVERNED BY,
AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

                  10.8. ADJUSTMENT OF SHARES. Each reference to a number of
shares of Common Stock in this Agreement shall be adjusted proportionately to
reflect any stock dividend, split or reverse split or the like affected with
respect to all outstanding shares of New Common Stock.

                  10.9. NO INCONSISTENT AGREEMENTS. The Company will not on or
after the date of this Agreement enter into any agreement with respect to its
securities which is inconsistent with the rights granted to the Securities
Holders in this Agreement or otherwise conflicts with the provisions hereof.

                  10.10. SEVERABILITY. Any provision of this Agreement
prohibited or rendered unenforceable by any applicable law of any jurisdiction
shall as to such jurisdiction be ineffective to the extent of such prohibition
or unenforceability, without invalidating the remaining provisions hereof, and
any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction.

                  10.11. ENTIRE AGREEMENT. THIS AGREEMENT CONSTITUTES THE ENTIRE
AGREEMENT AMONG THE PARTIES HERETO AND MAY NOT BE CONTRADICTED BY EVIDENCE OF
PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES HERETO.
THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE PARTIES HERETO.

                  10.12. LISTING OF NEW COMMON STOCK. The Company shall use its
reasonable best efforts to cause the New Common Stock to be listed or admitted
to trading on the NASDAQ National Market.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                      -30-

<PAGE>

                  IN WITNESS WHEREOF, the parties hereto have executed this
Agreement as of the day and year first written above.

                       INNOVATIVE CLINICAL SOLUTIONS, LTD.

                       By: /s/ Michael T. Heffernan
                               ----------------------------------
                           Name:   Michael T. Heffernan
                           Title:  President and Chief Executive Officer

                       SECURITIES HOLDERS:

                       THIRD AVENUE TRUST ON BEHALF OF THIRD AVENUE VALUE FUND
                       SERIES
                       c/o Third Avenue Funds
                       767 Third Avenue
                       New York, NY 10017-2023

                       By: /s/ Martin J. Whitman
                               ----------------------------------
                           Name:   Martin J. Whitman
                           Title:  Chairman, Chief Executive Officer

                       AGGRESSIVE CONSERVATIVE INVESTMENT FUND, L.P. (f/k/a
                       M.J. Whitman Pilot Fish Opportunity Fund, L.P.)
                       767 Third Avenue
                       New York, NY 10017-2023

                       By: /s/ David M. Barse
                               ----------------------------------
                           Name:   David M. Barse
                           Title:  President

               [SIGNATURE PAGES TO REGISTRATION RIGHTS AGREEMENT]

<PAGE>

                       EQSF ADVISERS, INC., as sub-adviser for
                       SUN AMERICA STYLE SELECT SERIES
                       SMALL-CAP VALUE PORTFOLIO
                       767 Third Avenue
                       New York, NY 10017-2023

                       By: /s/ Martin J. Whitman
                           -------------------------------------------
                           Name:  Martin J. Whitman
                           Title: Chairman and Chief Executive Officer

                       M.J. WHITMAN ADVISERS, INC., as adviser for the
                       account of
                       ZELDA ROSS TRUST
                       767 Third Avenue
                       New York, NY 10017-2023

                       By: /s/ David M. Barse
                           ---------------------------------------------
                           Name:  David M. Barse
                           Title: President and Chief Operations Officer

               [SIGNATURE PAGES TO REGISTRATION RIGHTS AGREEMENT]

<PAGE>

                                                                      SCHEDULE 1

                               REGISTERABLE COMMON
                            AS OF THE EFFECTIVE DATE

<TABLE>
<CAPTION>
=============================================================================================================
                                                                           SHARES OF
                                                                          REGISTERABLE
                         SECURITIES HOLDER                                   COMMON            PERCENTAGE
-------------------------------------------------------------------------------------------------------------
<S>                                                                          <C>              <C>
Third Avenue Trust on behalf of Third Avenue Value Fund Series               5,308,740        44.240%
-------------------------------------------------------------------------------------------------------------
Aggressive Conservative Investment Fund, L.P.                                  243,540        2.030%
-------------------------------------------------------------------------------------------------------------
Sun America Style Select Series Small-Cap Value Portfolio                      108,000        0.900%
-------------------------------------------------------------------------------------------------------------
Zelda Ross Trust                                                                24,300        0.203%
-------------------------------------------------------------------------------------------------------------
                  TOTAL                                                      5,684,580       47.372%
=============================================================================================================
</TABLE>

<PAGE>

                                                                       EXHIBIT A

                        SECURITIES HOLDER'S QUESTIONNAIRE

                  Please complete and return immediately to Innovative Clinical
Solutions, Ltd. at the following address:

                  Attention: Chief Financial Officer

                  The information requested below is required for purposes of
any Public Sale Event pursuant to the Registration Rights Agreement dated as of
September __, 2000 (the "Agreement") that may be initiated from time to time. If
you do not furnish the Company with the requested information, you will not be
entitled to participate in any such registration. Unless otherwise defined
herein, capitalized terms shall have the meanings ascribed thereto in the
Agreement.

                  Please do not leave any request for information unanswered. If
your response to a request is "no" or "not applicable," please so state. If
additional space is required, please attach additional sheets to the end of this
Questionnaire, clearly identifying the portion hereof to which they relate.

                  If you have any questions regarding this Questionnaire, please
contact ______________________.

I.       Information required for notices.

Institution Name:         _______________________________________
Street Address:           _______________________________________
Post Office Box:          _______________________________________
City/State/Zip:           _______________________________________
Fed.  Tax ID.  No.        _______________________________________
(if any):                 _______________________________________

Telecopier Number:

Contacts (Please include alternative contacts).

1.       Name:            _______________________________________
         Title:           _______________________________________
         Function:        _______________________________________
         Business Telephone: ____________________________________

<PAGE>

                                                                       Exhibit A
                                                                          Page 2

2.       Name:            _______________________________________
         Title:           _______________________________________
         Function:        _______________________________________
         Business Telephone: ____________________________________

II. Information required by the Securities Act of 1933, as amended, and related
regulations.

                  A.       FEDERAL SECURITIES LAWS

                  1.       NAME AND ADDRESS.  Give your name and address exactly
as they should appear in any Prospectus.

                          _______________________________________
                          _______________________________________
                          _______________________________________
                          _______________________________________

                  2. OWNERSHIP OF REGISTERABLE COMMON. State the number of
shares of Registerable Common, if any, owned by you or your affiliates as of the
date hereof.

                  Shares of Registerable Common: ____________________________

                  3. BENEFICIAL OWNERSHIP OF NEW COMMON STOCK. Please furnish
the following information, in the tabular form indicated, as to the shares of
New Common Stock beneficially owned (see definition at end of Questionnaire) by
you (including amounts held in your Trust Department in discretionary accounts):

                                                          If such ownership is
                                                          shared with others,
                                                          indicate nature and
         Number of         Nature of                      extent of such
         Shares(1)         Beneficial Ownership(2)        Shared Ownership

----------------

       (1) Include shares which you have the right to acquire through the
exercise of options, warrants or other securities on or before 60 days after the
estimated date of the Prospectus.

       (2) Please indicate the extent to which you have sole voting power,
shared voting power, sole investment power and shared investment power with
respect to shares of New Common Stock you beneficially own.

                                      -2-

<PAGE>

                                                                       Exhibit A
                                                                          Page 3

                  4. DISCLAIMER OF BENEFICIAL OWNERSHIP. Please indicate below
the number and description of any shares of New Common Stock with respect to
which you disclaim beneficial ownership and whether such shares are included in
the figure(s) reported above.

                  5. FIVE PERCENT BENEFICIAL OWNERS. Please give the name and
address of any Person, corporation or other entity, other than the parties to
the Agreement, known to you to own beneficially 5% or more of the outstanding
New Common Stock (i.e., ______ shares or more).

NOTE: For purposes of your response to this question, the term "Person" includes
      two or more Persons acting as a partnership, limited partnership,
      syndicate, or other group for the purpose of acquiring, holding or
      disposing of the Company's securities.

                  6. UNDERWRITERS. Please describe briefly and state the nature
of any relationship or interest that you have or any associate of yours (see
definition at end of Questionnaire) has, in any underwriter of the securities to
be offered. If you are a member or controlling Person of a firm that may be an
underwriter of the securities to be offered, briefly describe your relationship
to, and interest in, such underwriter.

NOTE: The underwriters will be listed in the final amendment to the Registration
      Statement, a copy of which will be sent to you at a later date.

                  7. MATERIAL RELATIONSHIPS. Please list all material
relationships that you now have, or have had since _______________, with the
Company or any of its affiliates, other than your ownership of the New Common
Stock or your participation in the Company's bankruptcy case.

                  B.        NASD REGULATIONS.

                  8. NASD MEMBERSHIP. State whether you are a "member" of the
National Association of Securities Dealers, Inc. (the "NASD"), a "Person
associated with a member" or an "underwriter or a related Person" with respect
to the proposed offering.

NOTES:                     (1)      The NASD By-Laws define "member" to mean
                  either any broker or dealer admitted to membership in the
                  NASD.

                           (2) The NASD By-Laws define "Person associated with a
                  member" to mean every sole proprietor, partner, officer,
                  director or branch manager of any member, or any natural
                  Person occupying a similar status or performing similar
                  functions, or any natural Person engaged in the investment
                  banking or securities business who is directly or indirectly
                  controlling or controlled by such member, whether or not any
                  such Person is registered or exempt from Registration with the
                  NASD.

                           (3) The NASD has interpreted "underwriter or a
                  related Person" with respect to a proposed offering to include
                  an underwriter, underwriters' counsel, financial consultants
                  and advisers, finders, members of the selling or distribution
                  group, and any and all other Persons "associated with" or
                  "related to" any of such Persons.

                                      -3-

<PAGE>

                                                                       Exhibit A
                                                                          Page 4

                  9. PURCHASE BY NASD AFFILIATES. If your answer to the
preceding question was "yes," please furnish the following information, in the
tabular form indicated, as to all purchases and acquisitions (including
contracts to purchase or to acquire) by you, of warrants, options or any other
securities of the Company or any subsidiary thereof, during the preceding 12
months, as well as all proposed purchases or acquisitions by you which are to be
consummated in whole or in part prior to, at the time of or within six months
after the effectiveness of the Registration Statement.

<TABLE>
<CAPTION>
                          Purchaser or           Seller or               Amount and             Price or
                          Prospective            Prospective             Name of                Other
Date                      Purchaser              Seller                  Securities             Consideration
--------                  ------------           ------------            ------------           ------------
<S>                       <C>                    <C>                     <C>                    <C>
--------                  ------------           ------------            ------------           ------------
--------                  ------------           ------------            ------------           ------------
--------                  ------------           ------------            ------------           ------------
</TABLE>

                  10. DEALINGS WITH COMPANY. Please describe any other dealings
within the preceding 12 months not already described in response to the
foregoing questions between the Company or any subsidiary or controlling
shareholder thereof and any underwriter, related Person of such underwriter,
NASD member or Person associated with such member affiliated with you, as such
terms are defined in the Notes to Question 10.

                  THE UNDERSIGNED HEREBY REPRESENTS AND WARRANTS TO ANY PERSON
WHO MAY BE LIABLE IN RESPECT OF A REGISTRATION OR OTHER OFFERING PURSUANT TO THE
AGREEMENT THAT THE ANSWERS GIVEN IN THIS QUESTIONNAIRE ARE CORRECTLY STATED TO
THE KNOWLEDGE, INFORMATION AND BELIEF OF THE UNDERSIGNED. THE UNDERSIGNED HEREBY
AGREES TO PROMPTLY NOTIFY THE COMPANY OF ANY CHANGE IN SUCH ANSWERS WHICH MAY
OCCUR DURING THE PERIOD BEGINNING WITH THE DATE BELOW AND ENDING ON THE DATE 90
DAYS AFTER THE EFFECTIVE DATE OF ANY REGISTRATION STATEMENT RELATING TO A
REGISTRATION OR OTHER OFFERING PURSUANT TO THE AGREEMENT. THE UNDERSIGNED HEREBY
AGREES, FOLLOWING NOTICE OF ANY PROPOSED REGISTRATION TO UPDATE AND AMEND THIS
QUESTIONNAIRE IF THERE IS ANY MATERIAL CHANGE IN THE ABOVE INFORMATION AND TO
PROVIDE ANY ADDITIONAL INFORMATION REQUESTED BY THE COMPANY PURSUANT TO THE
AGREEMENT.

Dated:  ______________, 19__.

                                    Holder:
                                             ------------------------------
                                    By:
                                             ------------------------------
                                    Name:
                                             ------------------------------
                                    Title:
                                             ------------------------------

                                      -4-

<PAGE>

                                   DEFINITIONS

As used in this Questionnaire:

                  "AFFILIATE" means a Person or organization that directly, or
indirectly through one or more intermediaries, controls, or is controlled by, or
is under common control with, the Company.

                  An "ASSOCIATED PERSON" means (1) any corporation or
organization (other than the Company or a majority owned subsidiary) of which
you are an executive officer or partner or are, directly or indirectly, the
beneficial owner of 10% or more of any class or equity securities and (2) any
trust or other estate in which you have substantial beneficial interest or to
which you serve as trustee or in a similar fiduciary capacity.

                  Securities "OWNED BENEFICIALLY" by you are securities (whether
or not registered in your name) in which you have or share (directly or
indirectly through any contract, arrangement, understanding, relationship or
otherwise) (i) voting power, which includes the power to vote or direct the
voting of the securities, or (ii) investment power, which includes the power to
dispose, or direct the disposition, of the securities. You are also deemed to be
the beneficial owner of any securities which you have the right to acquire
immediately or within 60 days (a) through the exercise of any option, warrant or
right, (b) through the conversion of a security or (c) pursuant to the power to
revoke, or the automatic termination of, a trust, discretionary account or
similar arrangement.

                  Thus, securities held in the name of other individuals, in the
name of an estate or trust or pursuant to a pledge agreement where you have
either the power to direct the voting of the securities or the disposition of
such securities should be listed as "owned beneficially" by you. The Commission
has also taken the position that securities held by your spouse, minor children,
or other relatives sharing your home should be shown as "owned beneficially" by
you on the theory that, absent special circumstances you are able to exercise a
controlling influence over the purchase, sale or voting of such securities.

<PAGE>

                                    EXHIBIT B

                              SUPPLEMENTAL ADDENDUM

                  The undersigned is a holder of New Common Stock of Innovative
Clinical Solutions, Ltd. The undersigned hereby agrees as follows:

                  The undersigned hereby accepts the terms of and becomes a
party to (as a Securities Holder) the Registration Rights Agreement dated as of
_______________, 2000 by and among Innovative Clinical Solutions, Ltd. (the
"Company") and each Securities Holder named therein. In connection therewith,
the undersigned agrees to (A) assume all obligations and liabilities thereunder,
(B) enjoy all of the rights thereunder, (C) be bound thereby and (D) perform and
comply with the agreements and commitments on the part of the undersigned, as
assignee, set forth in the Registration Rights Agreement.

                  As used in this Supplemental Addendum, capitalized terms
defined in the Registration Rights Agreement shall have their respective defined
meanings.

                                         Name of
Address:                                 Institution:_____________________

                                         By____________________________
                                           Title:

Date: _______________, _____

                                      (i)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}]]